The results of treating gastric and duodenal peptic ulcer by using the millimeter-range wavelength.
[Article in Russian]
Vinogradov VG, Kisel’ LK, Mager NV.
Abstract
Complex treatment of peptic ulcer with drugs and millimeter
electromagnetic waves (MEW) allows to shorten stay in hospital by 2
weeks. Ambulatory MEW therapy may be effective even if used without any
drugs, especially in young patients with fresh ulcer. Thus, MEW
treatment is recommended by the authors to be widely applied for the
treatment of peptic ulcer both in hospital and out-patient departments.
Lik Sprava. 1992 Aug;(8):36-8.
The local treatment of patients with a duodenal ulcer with millimeter-range electromagnetic radiation.
[Article in Ukrainian]
Zly? MV, Netiazhenko VZ, Zly? VV.
Abstract
A technique was designed for the treatment of duodenal ulcer patients
by electromagnetic radiation of the millimeter range (ERMR); 30
patients were treated by this method, while 50 patients received
traditional therapy; other patients were treated by lasers, cithemidin.
Endoscopic ERMR treatment in combination with drugs was more effective
than other methods.
Vrach Delo. 1991 May;(5):59-61.
The effect of hypnotic suggestion and millimeter-range
electromagnetic radiation on the clinical and endoscopic indices in
peptic ulcer patients.
[Article in Russian]
Nikula TD, Kan EB.
Abstract
The authors studied the effect of microwave resonance therapy,
hypnosuggestion and their combinations on the dynamics of
clinico-endoscopic indices in 182 patients with duodenal ulcer. It was
established that these methods were highly effective allowing to control
rapidly the pain syndrome, to achieve complete healing of the ulcer in
70-95% of cases within 14.8-16.7 days. The results were best when the
two methods were combined.
Vrach Delo. 1990 May;(5):6-9.
The use of millimeter-range electromagnetic radiation for treating peptic ulcer.
[Article in Russian]
Dogotar’ VB, Tkach SM, Perederi? VG, Kuzenko IuG.
Abstract
The efficacy was studied of treatment of ulcer disease by means of
microwave resonance radiation. It was established that this method of
treatment has advantages over traditional drug therapy in patients
harbouring the ulcer in the duodenum. The authors describe
contraindications to the use of this method, determine the duration of
treatment.
The effects of millimeter (40 GHz) and centimeter (8.15-18.00 GHz)
low-intensity waves on the production of tumor necrosis factor (TNE) in
macrophages and lymphocytes from exposed mice as well as in exposed
isolated cells were compared. It was found that the dynamics of TNF
secretory activity of cells varies depending on the frequency and
duration of exposure. The application of millimeter waves induced a
nonmonotonous course of the dose-effect curve for TNF changes in
macrophages and splenocytes. Alternately, a stimulation and a decrease
in TNF production were observed following the application of millimeter
waves. On the contrary, centimeter waves provoked an activation in
cytokine production. It is proposed that, in contrast to millimeter
waves, the single application of centimeter waves to animals (within 2
to 96 h) or isolated cells (within 0.5 to 2.5 h) induced a much more
substantial stimulation of immunity.
Biofizika. 2002 Mar-Apr;47(2):376-81.
Immunomodulating effect of electromagnetic waves on production of
tumor necrosis factor in mice with various rates of neoplasm growth.
Institute of Cell Biophysics, Russian Academy of Sciences, Pushchino, Moscow Region, 142290 Russia.
Abstract
The effects of low-density centimeter waves (8.15-18 GHz, 1
microW/cm2, 1 h daily for 14 days; MW) on tumor necrosis factor
production in macrophages of mice with different growth rate of a cancer
solid model produced after hypodermic injection of Ehrlich carcinoma
ascites cells into hind legs were studied. After irradiation, an
increase in the concentration of tumor necrosis factor in
immunocompetent cells of healthy and, specially, of tumor-bearing
animals was observed; and the effect of stimulation was higher upon
exposure of mice carrying rapidly growing tumors. We suggest that the
significant immunomodulating effect of low-density microwaves can be
utilized for tumor growth suppression.
Biofizika. 2001 Jan-Feb;46(1):131-5.
Effect of centimeter microwaves and the combined magnetic field on
the tumor necrosis factor production in cells of mice with experimental
tumors.
Institute of Cell Biophysics, Russian Academy of Sciences, Pushchino, Moscow Region, 142290 Russia.
Abstract
The effect of fractionated exposure to low-intensity microwaves
(8.15-18 GHz, 1 microW/cm2, 1.5 h daily for 7 days) and combined weak
magnetic field (constant 65 1 microT; alternating–100 nT, 3-10 Hz) on
the production of tumor necrosis factor in macrophages of mice with
experimental solid tumors produced by transplantation of Ehrlich ascites
carcinoma was studied. It was found that exposure of mice to both
microwaves and magnetic field enhanced the adaptive response of the
organism to the onset of tumor growth: the production of tumor necrosis
factor in peritoneal macrophages of tumor-bearing mice was higher than
in unexposed mice.
Effect of magnetic and ultrasound therapy on clinical manifestations
and general parameters of efficiency in the treatment of pulmonary
tuberculosis.
[Article in Ukrainian]
Savchenko VI, Samosiuk IZ.
The authors have analized general efficiency coefficients of the
treatment of 117 patients with the first diagnized pulmonary
tuberculosis. The patients were divided into a control and main group.
61 patients of the main group at the initial stage of complex treatment
in addition to a standard chemotherapy have recieved magnetic and
ultrasound therapy. During the treatment the patients underwent complex
clinical and X-ray examination. The patients of the main group have been
detected to have better signs of recovering compared with the control
group. The signs were the following: more rapid disappearing of main
clinical symptoms, radiological marks of tuberculosis such as focal and
infiltrative alterations and decay cavity closing, cessation of
bacterioexcretion.
Probl Tuberk. 2000;(2):18-21.
Magnetic laser therapy in combination with lymphotropic drugs
administration in treating teenagers with common forms of tuberculosis.
The paper shows the efficiency of combined use of magnetic laser
therapy (MLT) and lymphotropic drug therapy in 40 teenagers with common
forms of tuberculosis. The use of laser makes it possible to modify
methods of regional lymphotropic therapy, to prolong its use and
increase indications for it. MLT in combination with lymphotropic drug
therapy accelerates positive changes and hence enhances the efficiency
of tuberculosis treatment.
Probl Tuberk. 2001;(2):11-2.
Very high frequency electromagnetic irradiation in multimodal
treatment of patients with disseminated infiltrative pulmonary
tuberculosis.
[Article in Russian]
Iakovleva LP, Lineva ZE, Mozhokina GN.
Multimodality treatment involving very high-frequency electromagnetic
radiation (VHFER) in combination with the antioxidants alpha-tocopherol
and sodium thiosulfate, which had been performed in 27 patients with
disseminated infiltrative pulmonary tuberculosis, was effective. As
compared to patients receiving chemotherapy in combination with
electromagnetic radiation (n = 29) and routine chemotherapy alone (n =
29), these patients had more benefits from the multimodality treatment
in terms of bacterial isolation cessation and reduced hospital stay by
1.5-2 months, minimal pneumofibrotic changes occurred in 63% of the
patients. Combined VHFER and antioxidative therapy were found to exert a
normalizing effect on lipid peroxidation and immunity.
Probl Tuberk. 1999;(6):30-2.
Impact of combined magnetic and laser radiation of regional
pulmonary blood flow in patients with destructive pulmonary
tuberculosis.
[Article in Russian]
Iakubenia ON, Tostik SI, Iakubenia GI.
Rheopulmonography was used to study regional pulmonary blood flow in
30 patients with destructive pulmonary tuberculosis before and after
combined magnetic and laser radiation (an experimental group) and in 28
patients receiving the routine chemotherapy (a control group). The use
of combined exposure of a constant magnetic field and laser radiation
was found to promote pulmonary vascular tone, better microcirculatory
blood flow, and increased pulse blood filling in the affected portion of
the lung.
Probl Tuberk. 1997;(6):50-3.Links
Use of centimetric range microwave therapy in multimodality of treatment patients with destructive pulmonary tuberculosis.
[Article in Russian]
Savula MM, Kravchenko NS.
Centimeter microwave therapy (CMWT) was employed in the multimodality
treatment of 50 patients with destructive pulmonary tuberculosis. Its
results were compared with a matched control group comprising 43
patients. CMWT increased the rate of decay cavity closure, improved
bronchial patency and prevented its deterioration. This was followed by
improved lipid peroxidation, antioxidative activity, and an
immunological responsiveness of the body.
Probl Tuberk. 1995;(6):17-20.
Significance of the functional state of blood phagocytes in the
choice of optimal regime of EHF therapy of patients with pulmonary
tuberculosis.
[Article in Russian]
Novikova LN, Kaminskaia GO, Efimova LN.
A trial entered 136 patients with active tuberculosis of the lungs.
86 patients received conventional chemotherapy and a course of microwave
therapy. Control patients received chemotherapy alone. Phagocyte cell
viability and NB-test served as assessment laboratory criteria.
Millimetric waves in the treatment of pulmonary tuberculosis potentiate
the treatment efficacy documented as more rapid infiltration resolution
and cavern closure through the mechanism of normalization of phagocyte
cell function. The choice of wave length is principal: 5.6 mm waves
affect phagocyte function negatively, 6.4 mm waves produce more
significant positive effect in young patients with new local lesions
while 7.1 mm waves in older patients and in severe involvement. In vitro
radiation of the patients’ blood using different wave lengths and
subsequent performance of NB-test provides objective information for
choice of optimal treatment regimen.
Probl Tuberk. 1994;(4):2-4.
Effectiveness of chemotherapy combined with ultrahigh-frequency
electromagnetic radiation for the treatment of patients with pulmonary
tuberculosis.
[Article in Russian]
Khomenko AG, Chukanov VI, Novikova LN.
A procedure was developed to determine the optimum wavelength used
for each patient individually. Ultrahigh-frequency electromagnetic
radiation was studied in 54 patients with various pulmonary tuberculosis
forms for its impact on the course of the disease. Treatment was
performed by using a YAVOR device at 6.4 and 7.1 mm. Is was found that
following 10 sessions of UHF therapy used in combination with specific
chemicals, caverns were closed in 50% of patients 2-3 months after
therapy and in the controls 5-6 months later. Infiltrates in the lesion
areas were resolved 2-3 weeks after UHF exposure, whereas in the
controls 1-2 months following drug therapy alone.
Tubal pregnancy: the experience of early rehabilitative treatment.
[Article in Russian]
Strugatskii VM, Strizhakov AN, Shmeleva SV.
The surgical treatment for tubal pregnancy including laparoscopy and
antibacterial therapy were combined in 30 females with early start (on
postoperative day 1) of rehabilitation: psychotherapy, diet, therapeutic
exercise, low-frequency magnetotherapy. Hysterosalpingography and
dynamic dopplerography assessed the effect as good.
The results of treatment of 86 patients with the use of
magnetotherapy in combination with galvanization and intratissue
electrophoresis are presented. To create an electric field, the
“Potok-1” apparatus with a density of current equal to 0.05-0.1 mA/cm2
was employed. Simultaneously, the “MAG-30” apparatus for low-frequency
magnetotherapy with induction of 30 mT and area of exposure of 20 cm2
was applied to a trophic ulcer site. The use of magnetogalvanotherapy in
the complex of treatment of trophic ulcers of the lower extremities is
recommended.
Pol Tyg Lek. 1991 Sep 9-30;46(37-39):717-9.
Use of magnetic field in treatment of trophic leg ulcers.
[Article in Polish]
Sieron A, Zmudzinski J, Cieslar G, Adamek M.
III Katedry i Kliniki Chorob Wewnetrznych Sl. AM w Bytomiu.
Theoretical basis and favourable therapeutical application of
magnetic field in case of trophic ulcerations of the lower limbs are
discussed. As a clinical example of such action a case of a 39-year old
female patient with trophic ulceration of the leg is presented.
Practical advantages of magnetotherapy in similar to the described case
patients are suggested.
Klin Khir. 1991;(7):60-3.
Treatment of trophic ulcers of the lower extremities using a magnetic field.
[Article in Russian]
Alekseenko AV, Gusak VV.
The experience with treatment of 126 patients with ulcerous-necrotic
lesion of the lower extremities of different genesis was summarized. A
comparative evaluation of the effectiveness of treatment depending on a
type of the magnetic field: the constant, alternating, or travelling
impulse one was carried out. The most effective was the use of a
travelling impulse magnetic field. The results of the investigation
performed give grounds to recommend the wide use of magnetotherapy in
the complex treatment of trophic ulcers of the lower extremities
Front Hum Neurosci. 2015 Jun 16;9:303. doi: 10.3389/fnhum.2015.00303. eCollection 2015.
Possible Mechanisms Underlying the Therapeutic Effects of Transcranial Magnetic Stimulation.
Chervyakov AV1, Chernyavsky AY2, Sinitsyn DO3, Piradov MA1.
Author information1Research Center of Neurology , Moscow , Russia.
2Moscow
Institute of Physics and Technology, Russian Academy of Sciences ,
Moscow , Russia ; Faculty of Computational Mathematics and Cybernetics,
Moscow State University , Moscow , Russia.
3Research
Center of Neurology , Moscow , Russia ; Semenov Institute of Chemical
Physics, Russian Academy of Sciences , Moscow , Russia.
Abstract
Transcranial magnetic stimulation
(TMS) is an effective method used to diagnose and treat many
neurological disorders. Although repetitive TMS (rTMS) has been used to
treat a variety of serious pathological conditions including stroke,
depression, Parkinson’s disease, epilepsy, pain, and migraines, the
pathophysiological mechanisms underlying the effects of long-term TMS
remain unclear. In the present review, the effects of rTMS on
neurotransmitters and synaptic plasticity are described, including the
classic interpretations of TMS effects on synaptic plasticity via
long-term potentiation and long-term depression. We also discuss the
effects of rTMS on the genetic apparatus of neurons, glial cells, and
the prevention of neuronal death. The neurotrophic effects of rTMS on
dendritic growth and sprouting and neurotrophic factors are described,
including change in brain-derived neurotrophic factor concentration
under the influence of rTMS. Also, non-classical effects of TMS related
to biophysical effects of magnetic fields are described, including the
quantum effects, the magnetic spin effects, genetic magnetoreception,
the macromolecular effects of TMS, and the electromagnetic theory of
consciousness. Finally, we discuss possible interpretations of TMS
effects according to dynamical systems theory. Evidence suggests that a
rTMS-induced magnetic field should be considered a separate physical
factor that can be impactful at the subatomic level and that rTMS is
capable of significantly altering the reactivity of molecules
(radicals). It is thought that these factors underlie the therapeutic
benefits of therapy with TMS. Future research on these mechanisms will
be instrumental to the development of more powerful and reliable TMS
treatment protocols.
Brain. 2012 Oct 5. [Epub ahead of print]
Magnetic flimmers: ‘light in the electromagnetic darkness’
Martens JW, Koehler PJ, Vijselaar J.
Source
1 Department of Humanities, Utrecht University, Utrecht, The Netherlands.
Abstract
Transcranial magnetic stimulation has become an important field for
both research in neuroscience and for therapy since Barker in 1985
showed that it was possible to stimulate the human motor cortex with an
electromagnet. Today for instance, transcranial magnetic stimulation can
be used to measure nerve conduction velocities and to create virtual
lesions in the brain. The latter option creates the possibility to
inactivate parts of the brain temporarily without permanent damage. In
2008, the American Food and Drugs Administration approved repetitive
transcranial magnetic stimulation as a therapy for major depression
under strict conditions. Repetitive transcranial magnetic stimulation
has not yet been cleared for treatment of other diseases, including
schizophrenia, anxiety disorders, obesity and Parkinson’s disease, but
results seem promising. Transcranial magnetic stimulation, however, was
not invented at the end of the 20th century. The discovery of
electromagnetism, the enthusiasm for electricity and electrotherapy, and
the interest in Beard’s concept of neurasthenia already resulted in the
first electromagnetic treatments in the late 19th and early 20th
century. In this article, we provide a history of electromagnetic
stimulation circa 1900. From the data, we conclude that Mesmer’s late
18th century ideas of ‘animal magnetism’ and the 19th century absence of
physiological proof had a negative influence on the acceptance of this
therapy during the first decades of the 20th century. Electromagnetism
disappeared from neurological textbooks in the early 20th century to
recur at the end of that century.
Stroke. 2005 Oct 27; [Epub ahead of print]
Repetitive Transcranial Magnetic Stimulation of Contralesional Primary Motor Cortex Improves Hand Function After Stroke.
Takeuchi N, Chuma T, Matsuo Y, Watanabe I, Ikoma K.
From the Department of Rehabilitation Medicine, Hokkaido University Graduate School of Medicine, Sapporo 060-0814, Japan.
BACKGROUND AND PURPOSE: A recent report has demonstrated that the
contralesional primary motor cortex (M1) inhibited the ipsilesional M1
via an abnormal transcallosal inhibition (TCI) in stroke patients. We
studied whether a decreased excitability of the contralesional M1
induced by 1 Hz repetitive transcranial magnetic stimulation (rTMS)
caused an improved motor performance of the affected hand in stroke
patients by releasing the TCI.
METHODS: We conducted a double-blind study of real versus sham rTMS
in stroke patients. After patients had well- performed motor training to
minimize the possibility of motor training during the motor
measurement, they were randomly assigned to receive a subthreshold rTMS
at the contralesional M1 (1 Hz, 25 minutes) or sham stimulation.
RESULTS: When compared with sham stimulation, rTMS reduced the
amplitude of motor-evoked potentials in contralesional M1 and the TCI
duration, and rTMS immediately induced an improvement in pinch
acceleration of the affected hand, although a plateau in motor
performance had been reached by the previous motor training. This
improvement in motor function after rTMS was significantly correlated
with a reduced TCI duration.
CONCLUSIONS: We have demonstrated that a disruption of the TCI by the
contralesional M1 virtual lesion caused a paradoxical functional
facilitation of the affected hand in stroke patients; this suggests a
new neurorehabilitative strategy for stroke patients.
Schizophr Bull. 2005 Oct 27; [Epub ahead of print]
Therapeutic Effects of Individualized Alpha Frequency Transcranial
Magnetic Stimulation ({alpha} TMS) on the Negative on the Negative
Symptoms of Schizophrenia.
Jin Y, Potkin SG, Kemp AS, Huerta ST, Alva G, Thai TM, Carreon D, Bunney WE Jr.
Department of Psychiatry and Human Behavior, University of California, Irvine, School of Medicine.
Previous research in clinical electroencephalography (EEG) has
demonstrated that reduction of alpha frequency (8-13 Hz) EEG activity
may have particular relevance to the negative symptoms of schizophrenia.
Repetitive Transcranial Magnetic Stimulation (rTMS) was utilized to
investigate this relationship by assessing the therapeutic effects of
stimulation set individually at each subject’s peak alpha frequency
(alphaTMS). Twenty-seven subjects, with predominantly negative symptom
schizophrenia, received 2 weeks of daily treatment with either alphaTMS,
3 Hz, 20 Hz, or sham stimulation bilaterally over the dorsolateral
prefrontal cortex. Individualized alphaTMS demonstrated a significantly
larger (F 3,33 = 4.7, p = .007) therapeutic effect (29.6% reduction in
negative symptoms) than the other 3 conditions (< 9%). Furthermore,
these clinical improvements were found to be highly correlated (r =
0.86, p = .001) with increases (34%) in frontal alpha amplitude
following alphaTMS. These results affirm that the resonant features of
alpha frequency EEG play an important role in the pathophysiology of
schizophrenia and merit further investigation as a particularly
efficacious frequency for rTMS treatments.
Neuroreport. 2005 Nov 7;16(16):1839-42.
Effects of repetitive transcranial magnetic stimulation in depression: a magnetoencephalographic study.
Maihofner C, Ropohl A, Reulbach U, Hiller M, Elstner S, Kornhuber J, Sperling W.
Departments of aNeurology bPsychiatry and Psychotherapy cInstitute
for Experimental Physiology and Pathophysiology, University of Erlangen –
Nuremberg, Erlangen, Germany.
Recently, repetitive transcranial magnetic stimulation has evolved as
a potential therapeutic tool to interfere with brain changes associated
with neurological and psychiatric diseases. Little is known about its
mode of action, however. Here, we investigated effects of repetitive
transcranial magnetic stimulation on spontaneous magnetoencephalographic
activity in patients with major depression. Before treatment, depressed
patients showed a significant increase in slow magnetoencephalographic
activity (2-6 Hz) over the left prefrontal cortex, compared with healthy
controls. This activity significantly decreased during 10 days of
repetitive transcranial magnetic stimulation, paralleled by clinical
improvement. We conclude that therapeutic repetitive transcranial
magnetic stimulation effects can be mirrored by changes of spontaneous
magnetoencephalographic activity.
Psychiatry Res. 2005 Nov 15;137(1-2):1-10. Epub 2005 Oct 12.
Transcranial magnetic stimulation in treatment-resistant depressed patients: A double-blind, placebo-controlled trial.
Rossini D, Lucca A, Zanardi R, Magri L, Smeraldi E.
Department of Psychiatry, School of Medicine, Vita-Salute University,
San Raffaele Hospital, via Stamira d’Ancona 20, Milan 20127, Italy.
This 5-week, randomized, double-blind, placebo-controlled trial
investigated the efficacy and tolerability of high frequency repetitive
transcranial magnetic stimulation (rTMS) directed to the left prefrontal
cortex in drug-resistant depressed patients. Fifty-four patients were
randomly assigned to receive 10 daily applications of either real or
sham rTMS. Subjects assigned to receive active stimulation were divided
into two further subgroups according to the intensity of stimulation:
80% vs. 100% of motor threshold (MT). At study completion, the response
rates were 61.1% (n=11), 27.8% (n=5) and 6.2% (n=1) for the 100% MT
group, 80% MT group and sham group, respectively. A significant
difference (Pearson chi(2) test) was found between the 100% MT and sham
groups, while the 80% MT group did not differ significantly from the
sham group. Between the two active groups, a marginally significant
difference was observed. Analysis of variance with repeated measures on
Hamilton Depression Rating Scale scores revealed a significantly
different decrease over time of depressive symptomatology among the
three treatment groups. Treatment response appeared to be unrelated to
the demographic and clinical characteristics recorded, and on the whole
the technique was well tolerated. The results of this double-blind trial
showed that rTMS may be a useful and safe adjunctive treatment for
drug-resistant depressed patients.
Neuroreport. 2005 Nov 7;16(16):1849-1852.
Repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex affects strategic decision-making.
Wout MV, Kahn RS, Sanfey AG, Aleman A.
aDepartment of Psychonomics, Helmholtz Research Institute, University
of Utrecht bDepartment of Psychiatry, Rudolf Magnus Institute of
Neuroscience, University Medical Center Utrecht, Utrecht cBCN
NeuroImaging Center, Groningen, The Netherlands dDepartment of
Psychology, University of Arizona, Tucson, Arizona, USA.
Although decision-making is typically seen as a rational process,
emotions play a role in tasks that include unfairness. Recently,
activation in the right dorsolateral prefrontal cortex during offers
experienced as unfair in the Ultimatum Game was suggested to subserve
goal maintenance in this task. This is restricted to correlational
evidence, however, and it remains unclear whether the dorsolateral
prefrontal cortex is crucial for strategic decision-making. The present
study used repetitive transcranial magnetic stimulation in order to
investigate the causal role of the dorsolateral prefrontal cortex in
strategic decision-making in the Ultimatum Game. The results showed that
repetitive transcranial magnetic stimulation over the right
dorsolateral prefrontal cortex resulted in an altered decision-making
strategy compared with sham stimulation. We conclude that the
dorsolateral prefrontal cortex is causally implicated in strategic
decision-making in healthy human study participants.
Psychiatry Res. 2005 Nov 15;137(1-2):113-21. Epub 2005 Oct 11.
Chronic repetitive transcranial magnetic stimulation is
antidepressant but not anxiolytic in rat models of anxiety and
depression.
Hargreaves GA, McGregor IS, Sachdev PS.
School of Psychiatry, University of New South Wales, Sydney, 2052,
Australia; Neuropsychiatric Institute, Prince of Wales Hospital, Barker
Street, Randwick, NSW 2031, Australia.
Transcranial magnetic stimulation (TMS) has been proposed as a
treatment for depression and anxiety disorders. While the antidepressant
effect has been modelled in animals, there have been few attempts to
examine a possible anxiolytic effect of repetitive TMS (rTMS) in animal
models. We administered 18 days of rTMS to male Sprague-Dawley rats. On
days 10 through 18, rats were tested in several anxiety models (social
interaction, emergence, elevated plus-maze, and predator odor avoidance)
and in the forced swim test. No group differences were apparent on any
of the anxiety models, while TMS produced an antidepressant effect in
the forced swim test. Interestingly, on day 1 of the forced swim test,
the home cage control group displayed increased swimming behaviour
compared with sham-treated animals, suggesting an observable level of
stress may have accompanied sham treatment. The results from the forced
swim test suggested that TMS had modest antidepressant properties, but
it did not show anxiolytic properties in the models examined. The study
also suggested that stress associated with handling should be taken into
account in the interpretation of TMS studies in animals.
PLoS Biol. 2005 Oct 18;3(11):e362 [Epub ahead of print]
Improvement of Tactile Discrimination Performance and Enlargement of Cortical Somatosensory Maps after 5 Hz rTMS.
Tegenthoff M, Ragert P, Pleger B, Schwenkreis P, Forster AF, Nicolas V, Dinse HR.
Department of Neurology, Ruhr-University Bochum, BG-Kliniken Bergmannsheil, Bochum, Germany.
Repetitive transcranial magnetic stimulation (rTMS) is increasingly
used to investigate mechanisms of brain functions and plasticity, but
also as a promising new therapeutic tool. The effects of rTMS depend on
the intensity and frequency of stimulation and consist of changes of
cortical excitability, which often persists several minutes after
termination of rTMS. While these findings imply that cortical processing
can be altered by applying current pulses from outside the brain,
little is known about how rTMS persistently affects learning and
perception. Here we demonstrate in humans, through a combination of
psychophysical assessment of two-point discrimination thresholds and
functional magnetic resonance imaging (fMRI), that brief periods of 5 Hz
rTMS evoke lasting perceptual and cortical changes. rTMS was applied
over the cortical representation of the right index finger of primary
somatosensory cortex, resulting in a lowering of discrimination
thresholds of the right index finger. fMRI revealed an enlargement of
the right index finger representation in primary somatosensory cortex
that was linearly correlated with the individual rTMS-induced perceptual
improvement indicative of a close link between cortical and perceptual
changes. The results demonstrate that repetitive, unattended stimulation
from outside the brain, combined with a lack of behavioral information,
are effective in driving persistent improvement of the perception of
touch. The underlying properties and processes that allow cortical
networks, after being modified through TMS pulses, to reach new
organized stable states that mediate better performance remain to be
clarified.
Exp Neurol. 2005 Sep 26; [Epub ahead of print]
Repetitive transcranial magnetic stimulation of the dorsolateral
prefrontal cortex excitability in patients with major depressive
disorder.
Bajbouj M, Brakemeier EL, Schubert F, Lang UE, Neu P, Schindowski C, Danker-Hopfe H.
Department of Psychiatry, Charite-University Medicine Berlin, Campus Benjamin Franklin, Eschenallee 3, 14050 Berlin, Germany.
Repetitive transcranial magnetic stimulation (rTMS) of the
dorsolateral prefrontal cortex is a relatively non-invasive technique
with putative therapeutic effects in major depression. However, the
exact neurophysiological basis of these effects needs further
clarification. Therefore, we studied the impact of ten daily sessions of
left, dorsolateral prefrontal rTMS on motor cortical excitability, as
revealed by transcranial magnetic stimulation-elicited motor-evoked
potentials in 30 patients. As compared to the non-responders, responders
(33%) showed changes in parameters pointing towards a reduced cortical
excitability. These results suggest that repetitive transcranial
magnetic stimulation of the dorsolateral, prefrontal cortex may have
inhibitory effects on motor cortical neuronal excitability in patients
with major depressive disorder. Furthermore, measurement of motor
cortical excitability may be a useful tool for investigating and
monitoring inhibitory brain effects of antidepressant stimulation
techniques like rTMS.
Prog Brain Res. 2005;150:527-35.
Neural plasticity and recovery of function.
Ward NS.
Wellcome Department of Imaging Neuroscience, Institute of Neurology,
University College London, 12 Queen Square, London WC1N 3BG, UK.
Recovery of the function after stroke is a consequence of many
factors including resolution of oedema and survival of the ischaemic
penumbra. In addition there is a growing interest in the role of central
nervous system (CNS) reorganization. Much of the evidence supporting
this comes from animal models of focal brain injury, but non-invasive
techniques such as functional magnetic resonance imaging, transcranial
magnetic stimulation, electroencephalography and magnetoencephalography
now allow the study of the working human brain. Using these techniques
it is apparent that the motor system of the brain adapts to damage in a
way that attempts to preserve motor function. This has been demonstrated
after stroke, as part of the ageing process, and even after disruption
of normal motor cortex with repetitive transcranial magnetic
stimulation. The result of this reorganization is a new functional
architecture, one which will vary from patient to patient depending on
the anatomy of the damage, the biological age of the patient and lastly
the chronicity of the lesion. The success of any given therapeutic
intervention will depend on how well it interacts with this new
functional architecture. Thus it is crucial that the study of novel
therapeutic strategies for treating motor impairment after stroke take
account of this. This review maps out the attempts to describe
functionally relevant adaptive changes in the human brain following
focal damage. A greater understanding of how these changes are related
to the recovery process will allow not only the development of novel
therapeutic techniques that are based on neurobiological principles and
designed to minimize impairment in patients suffering from stroke, but
also to target these therapies at the appropriate patients.
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Oct 19; [Epub ahead of print]
A double-blind sham controlled study of right prefrontal repetitive
transcranial magnetic stimulation (rTMS): Therapeutic and cognitive
effect in medication free unipolar depression during 4 weeks.
Januel D, Dumortier G, Verdon CM, Stamatiadis L, Saba G, Cabaret W,
Benadhira R, Rocamora JF, Braha S, Kalalou K, Vicaut PE, Fermanian J.
Unite de recherche clinique, EPS de Ville Evrard a Saint Denis, G03, 5 Rue du Dr Delafontaine 93200 Saint-Denis, France.
BACKGROUND: Transcranial magnetic stimulation (TMS) has become a therapeutic tool in psychiatric diseases.
METHODOLOGY: The objective was to evaluate the efficacy of TMS in
unipolar depression: the percentage of responders (>50% HDRS
reduction) and remission (HDRS score </=8, after four weeks of active
TMS treatment in depressed patients free of any antidepressive agent
versus placebo-TMS.
RESULTS: 27 patients were randomized in two groups: rTMS (N=11)
versus sham TMS (N=16). Statistical differences were detected between
sham and TMS treated groups on remission (0/16 versus 4/11 p=0.032, 1/16
versus 6/11 0.028 and 1/16 versus 7/11 p=0.011 at day 14, day 21 and
day 28, respectively) and on response (2/16 versus 5/11 at day 14 (NS),
2/16 versus 7/11 p=0.0115 at day 21 and 1/16 versus 7/11 (p=0.025) day
28, respectively, using the exact Fisher test). Significant differences
were observed between day 1 versus day 8 (p<0.01), day 15, day 21 and
day 28 (p<0.001) in TMS group and only versus day 21 (p<0.01) and
day 28 (p<0.05) for the sham group. ANOVA comparison between TMS and
sham groups was significant at day 14 and day 28 (p<0.05).
LIMITATIONS: The few number of patients.
CONCLUSION: Our study has shown an efficacy of right rTMS in free
medication unipolar depression over a month. Nevertheless, number of
patients included is limited and multicentric studies will be necessary
to specify the antidepressive action of TMS.
Ann Neurol. 2005 Oct 20; [Epub ahead of print]
Altered plasticity of the human motor cortex in Parkinson’s disease.
Ueki Y, Mima T, Ali Kotb M, Sawada H, Saiki H, Ikeda A, Begum T, Reza F, Nagamine T, Fukuyama H.
Human Brain Research Center, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan.
Interventional paired associative stimulation (IPAS) to the
contralateral peripheral nerve and cerebral cortex can enhance the
primary motor cortex (M1) excitability with two synchronously arriving
inputs. This study investigated whether dopamine contributed to the
associative long-term potentiation-like effect in the M1 in Parkinson’s
disease (PD) patients. Eighteen right-handed PD patients and 11
right-handed age-matched healthy volunteers were studied. All patients
were studied after 12 hours off medication with levodopa replacement
(PD-off). Ten patients were also evaluated after medication (PD-on). The
IPAS comprised a single electric stimulus to the right median nerve at
the wrist and subsequent transcranial magnetic stimulation of the left
M1 with an interstimulus interval of 25 milliseconds (240 paired stimuli
every 5 seconds for 20 minutes). The motor-evoked potential amplitude
in the right abductor pollicis brevis muscle was increased by IPAS in
healthy volunteers, but not in PD patients. IPAS did not affect the
motor-evoked potential amplitude in the left abductor pollicis brevis.
The ratio of the motor-evoked potential amplitude before and after IPAS
in PD-off patients increased after dopamine replacement. Thus, dopamine
might modulate cortical plasticity in the human M1, which could be
related to higher order motor control, including motor learning. Ann
Neurol 2006.
HNO. 2005 Sep 17; [Epub ahead of print]
Treatment of chronic tinnitus with neuronavigated repetitive Transcranial Magnetic Stimulation (rTMS).
Klinik fur HNO-Heilkunde der Universitat Regensburg, .
BACKGROUND AND OBJECTIVE: Idiopathic tinnitus is a frequent and
debilitating disorder of largely unknown pathophysiology. Focal brain
activation in the auditory cortex has recently been demonstrated in
chronic tinnitus. Low-frequency rTMS can reduce cortical
hyperexcitability.
PATIENTS AND METHODS: In 12 patients with chronic tinnitus, fusion of
[(18)F]deoxyglucose-PET and structural MRI (T1, MPRAGE) scans allowed
the area of increased metabolic activity in the auditory cortex to be
exactly identified; this area was selected as the target for rTMS. A
neuronavigational system adapted for TMS positioning enabled the
relative positions of the figure-8 coil and the target area to be
monitored. Repetitive TMS (110% motor threshold; 1 Hz; 2000 stimuli per
day over 5 days) was performed using a placebo-controlled crossover
design. A sham coil system was used for the placebo stimulation.
Treatment outcome was assessed with a specific tinnitus questionnaire
(Goebel and Hiller).
RESULTS: In all 12 patients an asymmetrically increased metabolic
activation of the gyrus of Heschl was detected. The tinnitus score was
significantly improved after 5 days of active rTMS, an effect not seen
after placebo stimulation.
CONCLUSION: These preliminary results show that neuronavigated rTMS
may improve our understanding and treatment of chronic tinnitus.
Clin Neurophysiol. 2005 Oct 24; [Epub ahead of print]
Transcranial magnetic and electrical stimulation compared: Does TES activate intracortical neuronal circuits?
Brocke J, Irlbacher K, Hauptmann B, Voss M, Brandt SA.
Department of Neurology, Berlin NeuroImaging Center, Charite, 10117 Berlin, Germany.
OBJECTIVE: To determine whether, and under which conditions,
transcranial electrical stimulation (TES) and transcranial magnetic
stimulation (TMS) can activate similar neuronal structures of the human
motor cortex, as indicated by electromyographic recordings.
METHODS: Focal TMS was performed on three subjects inducing a
postero-anterior directed current (p-a), TES with postero-anteriorly
(p-a) and latero-medially (l-m) oriented electrodes. We analyzed the
onset latencies and amplitudes (single-pulse) and intracortical
inhibition and excitation (paired-pulse).
RESULTS: TMS p-a and TES p-a produced muscle responses with the same
onset latency, while TES l-m led to 1.4-1.9ms shorter latencies.
Paired-pulse TMS p-a and TES p-a induced inhibition at short
inter-stimulus intervals (ISI) (maximum: 2-3ms) and facilitation at
longer ISIs (maximum: 10ms). No inhibition but a strong facilitation was
obtained from paired-pulse TES l-m (ISIs 1-5ms).
CONCLUSIONS: Our findings support the hypothesis, that current
direction is the most relevant factor in determining the mode of
activation for both TMS and TES: TMS p-a and TES p-a are likely to
activate the corticospinal neurons indirectly. In contrast, TES l-m may
preferentially activate the corticospinal fibres directly, distant of
the neuronal body. SIGNIFICANCE: TES is a suitable tool to induce
intracortical inhibition and excitation.
Neurosci Behav Physiol. 2005 Mar;35(3):313-7.
The effects of L-DOPA and transcranial magnetic stimulation on behavioral reactions in kindled rats.
Godlevskii LS, Kobolev EV.
Odessa State Medical University, 2 Valikhovskii Lane, 65026 Odessa, Ukraine.
Acute experiments were performed on rats to produce a model of
chronic epileptic activity–pharmacological kindling by repeated doses of
picrotoxin (1.0-1.2 mg/kg, i.p.). During the early period following
kindling (24 h from the last dose of epileptogen), animals showed
decreases in measures of investigative behavior as measured in an open
field test, along with reductions in sexual and feeding behavior. The
severity of these impairments had decreased by two weeks from the last
picrotoxin dose. Both treatment with L-DOPA (100 mg/kg, i.p.) and
transcranial magnetic stimulation (20 impulses with induction, peak 1.5
T) were accompanied by increases in measures of investigative, sexual,
and feeding behavior in the animals, suggesting that mechanism of action
of transcranial magnetic stimulation in relation to kindling-induced
behavioral abnormalities is mediated by activation of the dopaminergic
system of the brain.
Eur J Neurosci. 2005 Nov;22(9):2392-6.
High-frequency repetitive transcranial magnetic stimulation over the
hand area of the primary motor cortex disturbs predictive grip force
scaling.
Nowak DA, Voss M, Huang YZ, Wolpert DM, Rothwell JC.
Sobell Department of Motor Neuroscience and Movements Disorders, Institute of Neurology, University College London, London, UK.
When we repetitively lift an object, our grip force is influenced by
the mechanical object properties of the preceding lift, irrespective of
whether the subsequent lift is performed with the same hand or the hand
opposite to the preceding lift. This study investigates if repetitive
high-frequency transcranial magnetic stimulation (rTMS) over the
dominant primary motor cortex affects this relationship. After
completion of 10 lifts of an object using the dominant hand, rTMS was
applied over the dominant primary motor cortex for 20 s. On the first
lift following rTMS, the peak grip force was significantly higher than
on the lift preceding rTMS. Moreover, this measure remained elevated
throughout the following set of lifts after rTMS. rTMS did not change
the peak lift force generated by more proximal arm muscles. The same
effect was observed when the lifts following rTMS over the dominant
motor cortex were performed with the ipsilateral hand. These effects
were not observed when subjects rested both hands on their lap or when a
sham stimulation was applied for the same period of time. These
preliminary data suggest that rTMS over the sensorimotor cortex disturbs
predictive grip force planning.
J Psychiatr Res. 2005 Oct 28; [Epub ahead of print]
Striatal dopamine release after prefrontal repetitive transcranial
magnetic stimulation in major depression: Preliminary results of a
dynamic [(123)I] IBZM SPECT study.
Pogarell O, Koch W, Popperl G, Tatsch K, Jakob F, Zwanzger P, Mulert C, Rupprecht R, Moller HJ, Hegerl U, Padberg F.
Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstr. 7, D-80336 Munich, Germany.
Though there is considerable evidence that prefrontal repetitive
transcranial magnetic stimulation (rTMS) exerts antidepressant effects,
the neurobiological action of rTMS in patients with depression is poorly
understood. Preclinical studies in animals and humans have demonstrated
that prefrontal rTMS can induce dopamine release in mesostriatal and
mesolimbic regions. We therefore investigated whether rTMS also
modulates striatal dopaminergic neurotransmission in depressed patients
using a dynamic [(123)I] iodobenzamide (IBZM) single photon emission
computed tomography (SPECT) approach. Five patients with a major
depressive episode (DSM-IV) underwent an acute 10Hz rTMS challenge with
3000 stimuli over the left dorsolateral prefrontal cortex during an
[(123)I] IBZM-SPECT bolus and constant infusion protocol. In four
subjects the protocol was repeated after a three week rTMS standard
treatment. Striatal IBZM binding to dopamine D(2) receptors was assessed
with a region-of-interest (ROI) technique. The change in striatal IBZM
binding after the rTMS challenge was regarded as measure of change in
endogenous striatal dopamine. Data of nine SPECT investigations showed a
significant reduction by 9.6+/-6.2% in IBZM binding to striatal
dopamine D(2) receptors after rTMS challenge compared to baseline
(p=0.01, Wilcoxon test). In this preliminary study, the reduction of
IBZM binding observed after rTMS challenge is suggestive of a release in
endogenous dopamine induced by prefrontal rTMS. In future, this
approach can be used to differentiate specific and non-specific
reward-related effects of rTMS on dopaminergic neurotransmission.
Vision Res. 2005 Oct 26; [Epub ahead of print]
Processing of global form and motion in migraineurs.
Ditchfield JA, McKendrick AM, Badcock DR.
School of Psychology, University of Western Australia, 35 Stirling Hwy, Crawley, WA 6009, Australia.
Previous studies have identified anomalies of cortical visual
processing in migraineurs that appear to extend beyond V1. Migraineurs
respond differently than controls to transcranial magnetic stimulation
of V5, and can demonstrate impairments of global motion processing. This
study was designed to assess the integrity of intermediate stages of
both motion and form processing in people with migraine. We measured the
ability to integrate local orientation information into a global form
percept, and to integrate local motion information into a global motion
percept. Control subjects performed significantly better than
migraineurs on both tasks, suggesting a diffuse visual cortical
processing anomaly in migraine.
J Clin Neurosci. 2005 Oct 25; [Epub ahead of print]
The use of transcranial magnetic stimulation in the clinical evaluation of suspected myelopathy.
Chan YC, Mills KR.
Department of Clinical Neurophysiology, King’s College Hospital, London SE5 9RS.
Central motor conduction time (CMCT) and motor evoked potential (MEP)
latencies measured by using transcranial magnetic stimulation (TMS) are
parameters used to evaluate electrophysiologic function of the
corticospinal motor tract. We present 5 cases to illustrate how the use
of TMS had contributed to clinical management. CMCT and MEP latency
measurements were found to be useful in determining the significance of
lesions seen on neuroimaging and helped clinical decisions in the
presence of multiple lesions or multiple clinical conditions that cause
similar clinical manifestations. TMS study is particularly useful in
localizing levels of conduction defect.
Exp Brain Res. 2005 May;163(1):21-31. Epub 2005 Feb 3.
Silent period to transcranial magnetic
Kimiskidis VK, Papagiannopoulos S, Sotirakoglou K, Kazis DA, Kazis A, Mills KR.
Department of Neurology III, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, 57010 Thessaloniki, Greece. kimiskid@med.auth.gr
Silent period (SP) is widely used in transcranial magnetic
stimulation studies. Methodologically, SP is usually elicited at
stimulus intensities corresponding to a certain percentage of
corticomotor threshold. Because this approach might lead to factitious
SP changes, the present study was designed to develop, in a stepwise
manner, a method for investigating SP independently of corticomotor
threshold. First, stimulus-response (S-R) curves of SP against stimulus
intensity (SI) were constructed and quantitatively described in healthy
volunteers. Second, various methodological issues such as the optimum
model for describing the relationship between SP duration and SI and the
importance of the type of stimulating coil were addressed. Finally, the
proposed method and a commonly used method (eliciting SPs at 130% MT
SI) were directly compared for a group of epileptic patients for whom
administration of oxcarbazepine resulted in significant corticomotor
threshold elevation. Twenty-one subjects (eleven females, median age, 38
years) were studied. SPs were obtained with a figure-of-eight coil
using a standardized procedure (recording, FDI). Pilot experiments
indicated that at least four trials were required, at each intensity
level, to estimate the mean SP duration within 10% of the true mean.
Therefore, SPs were determined from the average of four trials with 5%
increments from 5 to 100% maximum SI. In a second set of experiments,
SPs were obtained for fifteen subjects using a circular coil. In a third
set of experiments, eight epileptic patients were studied before and
after administration of oxcarbazepine (mean dose 1553 mg, range 900-1800
mg). The S-R curves were fitted to a Boltzman function and to
first-order to fourth-order polynomial and sigmoid functions. The
Boltzman function described the data accurately (R2=0.947-0.990). In
addition, direct comparison of the six models with an F-test proved the
superiority of the first. The best-fit parameters of the reference
curve, i.e. the maximum and minimum values, the slope, and V50 (the SI
at which SP duration is halfway between Min and Max) were 230.8+/-3.31
ms (x+/-SEM), -11.51+/-3.31 ms, 11.56+/-0.65%, and 49.82+/-0.65%,
respectively. When the curves obtained with the circular coil were
compared with those obtained with the figure-of-eight coil, there were
differences between V50 (51.69+/-0.72 vs 47.95+/-0.82, P<0.001) and
SP threshold (31.15 vs 24.77, P<0.01) whereas the other best-fit
values did not differ significantly. Oxcarbazepine increased
corticomotor threshold from 45.3+/-5.8% at baseline to 59.4+/-10.4%
(P<0.001). According to the commonly used method, the drug
significantly prolonged SP (from 117.6+/-42.4 ms to 143.5+/-46.5 ms,
P<0.001) and, consequently, enhanced brain inhibition. In contrast,
study of the SP curves led to the conclusion that oxcarbazepine does not
affect the Max value and slope but significantly increases V50 and SP
threshold (from 54.5+/-4.9% to 59.9+/-7.2% and from 29.1+/-6.4% to
34.6+/-6.8%, respectively, P<0.01). These findings imply that
oxcarbazepine does not enhance brain inhibitory mechanisms. Thus, in
situations characterized by significant changes in corticomotor
threshold the proposed method provides results clearly different from a
commonly used approach. It is concluded that S-R curves obtained with a
figure-of-eight coil in 5% increments and fitted to a Boltzman function
provide an accurate, comprehensive, and clinically applicable method for
exploring SP.
Invest Radiol. 1998 Jun;33(6):336-40.
Echoplanar BOLD fMRI of brain activation induced by concurrent transcranial magnetic stimulation.
Bohning DE, Shastri A, Nahas Z, Lorberbaum JP, Andersen SW, Dannels WR, Haxthausen EU, Vincent DJ, George MS.
Department of Radiology, Medical University of South Carolina, Charleston 29425, USA. bohninde@musc.edu
RATIONALE AND OBJECTIVES: The authors demonstrate the feasibility of
combining transcranial magnetic stimulation (TMS) and functional
magnetic resonance imaging (fMRI) inside an MR scanner to noninvasively
stimulate and image regional brain activity.
METHODS: Echoplanar blood oxygen level dependent (BOLD)-based fMRI
studies of TMS response were performed on three human volunteers inside a
standard 1.5 T MR scanner using independent computer control to
interleave echoplanar image acquisition and stimulation of right thumb
primary motor cortex with a nonferromagnetic TMS coil.
RESULTS: Significant (P< 0.001) response was observed in motor
cortex under the TMS coil during stimulation compared to rest, as well
in auditory cortex, the latter presumably due to the loud “snap” when
the coil was pulsed.
CONCLUSIONS: Concurrent TMS stimulation and echoplanar BOLD fMRI
imaging is possible. This method has potential for tracing neural
circuits with brain imaging, as well as investigating the effects of
TMS.
Int J Neurosci. 1998 May;94(1-2):41-54.
Transcranial AC pulsed applications of weak electromagnetic fields
reduces freezing and falling in progressive supranuclear palsy: a case
report.
Sandyk R.
Department of Neuroscience, Institute for Biomedical Engineering and
Rehabilitation Services, Touro College, Dix Hills, NY 11746, USA.
Freezing is a common and disabling symptom in patients with
Parkinsonism. It affects most commonly the gait in the form of start
hesitation and sudden immobility often resulting in falling. A higher
incidence of freezing occurs in patients with progressive supranuclear
palsy (PSP) which is characterized clinically by a constellation of
symptoms including supranuclear ophthalmoplegia, postural instability,
axial rigidity, dysarthria, Parkinsonism, and pseudobulbar palsy.
Pharmacologic therapy of PSP is currently disappointing and the disease
progresses relentlessly to a fatal outcome within the first decade after
onset. This report concerns a 67 year old woman with a diagnosis of PSP
in whom freezing and frequent falling were the most disabling symptoms
of the disease at the time of presentation. Both symptoms, which were
rated 4 on the Unified Parkinson Rating Scale (UPRS) which grades
Parkinsonian symptoms and signs from 0 to 4, with 0 being normal and 4
being severe symptoms, were resistant to treatment with dopaminergic
drugs such as levodopa, amantadine, selegiline and pergolide mesylate as
well as with the potent and highly selective noradrenergic reuptake
inhibitor nortriptyline. Weekly transcranial applications of AC pulsed
electromagnetic fields (EMFs) of picotesla flux density was associated
with approximately 50% reduction in the frequency of freezing and about
80-90% reduction in frequency of falling after a 6 months follow-up
period. At this point freezing was rated 2 while falling received a
score of 1 on the UPRS. In addition, this treatment was associated with
an improvement in Parkinsonian and pseudobulbar symptoms with the
difference between the pre-and post EMF treatment across 13 measures
being highly significant (p < .005; Sign test). These results suggest
that transcranial administration AC pulsed EMFs in the picotesla flux
density is efficacious in the treatment of PSP.
Int J Neurosci. 1997 Nov;92(1-2):63-72.
Speech impairment in Parkinson’s disease is improved by transcranial application of electromagnetic fields.
Sandyk R.
Department of Neuroscience, Touro College, Dix Hills, NY 11746, USA.
A 52 year old fully medicated physician with juvenile onset
Parkinsonism experienced 4 years ago severe “on-off” fluctuations in
motor disability and debilitating speech impairment with severe
stuttering which occurred predominantly during “on-off” periods. His
speech impairment improved 20%-30% when sertraline (75 mg/day), a
serotonin reuptake inhibitor, was added to his dopaminergic medications
which included levodopa, amantadine, selegiline and pergolide mesylate. A
more dramatic and consistent improvement in his speech occurred over
the past 4 years during which time the patient received, on a fairly
regular basis, weekly transcranial treatments with AC pulsed
electromagnetic fields (EMFs) of picotesla flux density. Recurrence of
speech impairment was observed on several occasions when regular
treatments with EMFs were temporarily discontinued. These findings
demonstrate that AC pulsed applications of picotesla flux density EMFs
may offer a nonpharmacologic approach to the management of speech
disturbances in Parkinsonism. Furthermore, this case implicates cerebral
serotonergic deficiency in the pathogenesis of Parkinsonian speech
impairment which affects more than 50% of patients. It is believed that
pulsed applications of EMFs improved this patient’s speech impairment
through the facilitation of serotonergic transmission which may have
occurred in part through a synergistic interaction with sertraline.
Int J Neurosci. 1997 Sep;91(1-2):57-68.
Reversal of cognitive in an elderly parkinsonian patient by transcranial application of picotesla electromagnetic fields.
Sandyk R.
Department of Neuroscience, Touro College, Dix Hills, NY 11746, USA.
A 74 year old retired building inspector with a 15 year history of
Parkinson’s disease (PD) presented with severe resting tremor in the
right hand, generalized bradykinesia, difficulties with the initiation
of gait with freezing, mental depression and generalized cognitive
impairment despite being fully medicated. Testing of constructional
abilities employing various drawing tasks demonstrated drawing
impairment compatible with severe left hemispheric dysfunction. After
receiving two successive transcranial applications, each of 20 minutes
duration, with AC pulsed electromagnetic fields (EMFs) of 7.5 picotesla
flux density and frequencies of 5Hz and 7Hz respectively, his tremor
remitted and there was dramatic improvement in his drawing performance.
Additional striking improvements in his drawing performance occurred
over the following two days after he continued to receive daily
treatments with EMFs. The patient’s drawings were subjected to a
Reliability Test in which 10 raters reported 100% correct assessment of
pre- and post drawings with all possible comparisons (mean 2 = 5.0; p
< .05). This case demonstrates in PD rapid reversal of drawing
impairment related to left hemispheric dysfunction by brief transcranial
applications of AC pulsed picotesla flux density EMFs and suggests that
cognitive deficits associated with Parkinsonism, which usually are
progressive and unaffected by dopamine replacement therapy, may be
partly reversed by administration of these EMFs. Treatment with
picotesla EMFs reflects a “cutting edge” approach to the management of
cognitive impairment in Parkinsonism.
OBJECTIVE: The aim of this study was to investigate if laser therapy
in combination with pulsed electromagnetic field therapy/repetitive
transcranial magnetic stimulation (rTMS) and the control of reactive
oxygen species (ROS) would lead to positive treatment results for
hyperacusis patients.
BACKGROUND DATA: Eight of the first ten patients treated for
tinnitus, who were also suffering from chronic hyperacusis, claimed
their hyperacusis improved. Based upon that, a prospective, unblinded,
uncontrolled clinical trial was planned and conducted. ROS and
hyperacusis pain thresholds were measured.
MATERIALS AND METHODS: Forty-eight patients were treated twice a week
with a combination of therapeutic laser, rTMS, and the control and
adjustment of ROS. A magnetic field of no more than 100 microT was
oriented behind the outer ear, in the area of the mastoid bone. ROS were
measured and controlled by administering different antioxidants. At
every treatment session, 177-504 J of laser light of two different
wavelengths was administered toward the inner ear via meatus acusticus.
RESULTS: The improvements were significantly better in the verum
group than in a placebo group, where 40% of the patients were expected
to have a positive treatment effect. The patients in the long-term
follow-up group received significantly greater improvements than the
patients in the short-term follow-up group.
CONCLUSION: The treatment is effective in treating chronic hyperacusis.
HNO. 2006 Jun;54(6):439-44.
Treatment of chronic tinnitus with neuronavigated repetitive Transcranial Magnetic Stimulation (rTMS).
BACKGROUND AND OBJECTIVE: Idiopathic tinnitus is a frequent and
debilitating disorder of largely unknown pathophysiology. Focal brain
activation in the auditory cortex has recently been demonstrated in
chronic tinnitus. Low-frequency rTMS can reduce cortical
hyperexcitability.
PATIENTS AND METHODS: In 12 patients with chronic tinnitus, fusion of
[18F]deoxyglucose-PET and structural MRI (T1, MPRAGE) scans allowed the
area of increased metabolic activity in the auditory cortex to be
exactly identified; this area was selected as the target for rTMS. A
neuronavigational system adapted for TMS positioning enabled the
relative positions of the figure-8 coil and the target area to be
monitored. Repetitive TMS (110% motor threshold; 1 Hz; 2000 stimuli per
day over 5 days) was performed using a placebo-controlled crossover
design. A sham coil system was used for the placebo stimulation.
Treatment outcome was assessed with a specific tinnitus questionnaire
(Goebel and Hiller).
RESULTS: In all 12 patients an asymmetrically increased metabolic
activation of the gyrus of Heschl was detected. The tinnitus score was
significantly improved after 5 days of active rTMS, an effect not seen
after placebo stimulation.
CONCLUSION: These preliminary results show that neuronavigated rTMS
may improve our understanding and treatment of chronic tinnitus.
HNO. 2005 Sep 17; [Epub ahead of print]
Treatment of chronic tinnitus with neuronavigated repetitive Transcranial Magnetic Stimulation (rTMS).
Klinik fur HNO-Heilkunde der Universitat Regensburg, .
BACKGROUND AND OBJECTIVE: Idiopathic tinnitus is a frequent and
debilitating disorder of largely unknown pathophysiology. Focal brain
activation in the auditory cortex has recently been demonstrated in
chronic tinnitus. Low-frequency rTMS can reduce cortical
hyperexcitability.
PATIENTS AND METHODS: In 12 patients with chronic tinnitus, fusion of
[(18)F]deoxyglucose-PET and structural MRI (T1, MPRAGE) scans allowed
the area of increased metabolic activity in the auditory cortex to be
exactly identified; this area was selected as the target for rTMS. A
neuronavigational system adapted for TMS positioning enabled the
relative positions of the figure-8 coil and the target area to be
monitored. Repetitive TMS (110% motor threshold; 1 Hz; 2000 stimuli per
day over 5 days) was performed using a placebo-controlled crossover
design. A sham coil system was used for the placebo stimulation.
Treatment outcome was assessed with a specific tinnitus questionnaire
(Goebel and Hiller).
RESULTS: In all 12 patients an asymmetrically increased metabolic
activation of the gyrus of Heschl was detected. The tinnitus score was
significantly improved after 5 days of active rTMS, an effect not seen
after placebo stimulation.
CONCLUSION: These preliminary results show that neuronavigated rTMS
may improve our understanding and treatment of chronic tinnitus.
Otol Neurotol. 2005 Jul;26(4):616-9.
Transcranial magnetic stimulation for tinnitus: influence of
tinnitus duration on stimulation parameter choice and maximal tinnitus
suppression.
De Ridder D, Verstraeten E, Van der Kelen K, De Mulder G, Sunaert S, Verlooy J, Van de Heyning P, Moller A.
Department of Neurosurgery and Otorhinolaryngology, University Hospital Antwerp, Belgium. dirk.de.ridder@uza.be
OBJECTIVE: Tinnitus is a distressing symptom for which few treatments
exist. It leads to an important decrease in quality of life in 2 to 3%
of the population. Tinnitus is considered a phantom sound, the result of
cortical reorganization. Transcranial magnetic stimulation (TMS) is a
noninvasive method to modulate cortical reorganization and has been
shown to be able to influence tinnitus perception.
STUDY DESIGN: Retrospective analysis.
SETTING: Tertiary referral center.
PATIENTS: The effect of TMS of the contralateral auditory cortex in
114 patients with unilateral tinnitus is investigated as one of the
selection criteria used for surgical implantation of electrodes on the
auditory cortex.
INTERVENTION: TMS is performed at 90% of motor threshold at 1, 3, 5,
10, and 20 Hz, with each stimulation session consisting of 200 pulses.
Results were classified as no effect (0-19% improvement), partial effect
(20-79% improvement), and good effect (80-100 suppression). MAIN
OUTCOME MEASURES: TMS had a good effect in 25% of the patients studied,
partial effect in 28% patients, and no effect in 47%.
RESULTS: TMS at 200 pulses is capable of tinnitus suppression for
seconds only. The results were influenced by tinnitus duration: the
longer the tinnitus exists, the lower the stimulation frequency that
yields maximal tinnitus suppression (p < 0.001). The maximal amount
of tinnitus suppression decreases in time (p < 0.01), resulting in a
2% decrease of potential tinnitus suppression per year.
CONCLUSION: TMS of the auditory cortex is capable of modifying
tinnitus perception for a very short time. The maximal amount of
suppression and best stimulation frequency depends on the tinnitus
duration.
Electromagnetic stimulation as a treatment of tinnitus: a pilot study.
Roland NJ, Hughes JB, Daley MB, Cook JA, Jones AS, McCormick MS.
Department of Otolaryngology, Royal Liverpool University Hospital, UK.
This paper reports the results of a study to determine whether pulsed
electromagnetic stimulation, applied over the mastoid bone, caused an
improvement in the level of tinnitus in long-standing tinnitus
sufferers. Fifty-eight patients from the Liverpool Tinnitus Association
volunteered to take part in a double-blind placebo controlled trial.
Active and placebo devices were randomly allocated to these patients on
their first visit. At the end of one week of treatment, each patient
noted whether their tinnitus had completely disappeared, was improved,
unchanged or made worse by the treatment Forty-five per cent of the
patients who completed the trial were improved by the active device, but
only 9% by placebo (P = 0.0013, Mann-Whitney test). We suggest that
electromagnetic stimulation may be an effective treatment in some
tinnitus sufferers.
Vestn Otorinolaringol. 2002;(1):11-4.
Electrophysical effects in combined treatment of neurosensory hypoacusis.
[Article in Russian]
Morenko VM, Enin IP.
The authors consider different methods of electrobiophysical impacts
on the body in the treatment of neurosensory hypoacusis: laser beam,
laser puncture, electrostimulation, magnetotherapy, magnetolasertherapy,
electrophoresis, etc. These methods find more and more intensive
application in modern medicine. Further success of physiotherapy for
neurosensory hypoacusis depends on adequate knowledge about mechanisms
of action of each physical method used and introduction of novel
techniques.
Vestn Otorinolaringol. 2001;(4):10-2.
Cerebral hemodynamics in patients with neurosensory hearing loss before and after magnetotherapy.
[Article in Russian]
Morenko VM, Enin IP.
Magnetotherapy effects on cerebral hemodynamics were studied using
rheoencephalography (REG). When the treatment results and changes in
cerebral hemodynamics were compared it was evident that normalization or
improvement of vascular status in vertebrobasilar and carotid
territories registered at REG results in better hearing. This confirms
the role of vascular factor in pathogenesis of neurosensory hypoacusis
of different etiology and effectiveness of magnetotherapy in such
patients.
Vestn Otorinolaringol. 1996 Nov-Dec;(6):23-6.
The treatment of hypoacusis in children by using a pulsed low-frequency electromagnetic field.
[Article in Russian]
Bogomil’skii MR, Sapozhnikov IaM, Zaslavskii AIu, Tarutin NP.
The authors provide specifications of the unit INFITA supplied with
ELEMAGS attachment of their own design; the technique of treating
hypoacusis in children with utilization of impulse low-frequency
electromagnetic field; the results of this treatment in 105 hypoacusis
children. The method was found highly effective and valuable for wide
practice.
Med Tekh. 1995 Mar-Apr;(2):40-1.
ELEMAGS apparatus and clinical experience in its use in the treatment of children with hypoacusis and otalgia.
To enhance effectiveness of magnetotherapy in the treatment of otic
diseases the authors propose to use impulse low-frequency
electromagnetic field in combination with constant magnetic field.
ELEMAGS equipment based on the above principles is introduced to treat
cochlear neuritis and neurosensory hypoacusis in children.
Klinik fur HNO-Heilkunde der Universitat Regensburg, .
BACKGROUND AND OBJECTIVE: Idiopathic tinnitus is a frequent and
debilitating disorder of largely unknown pathophysiology. Focal brain
activation in the auditory cortex has recently been demonstrated in
chronic tinnitus. Low-frequency rTMS can reduce cortical
hyperexcitability.
PATIENTS AND METHODS: In 12 patients with chronic tinnitus, fusion of
[(18)F]deoxyglucose-PET and structural MRI (T1, MPRAGE) scans allowed
the area of increased metabolic activity in the auditory cortex to be
exactly identified; this area was selected as the target for rTMS. A
neuronavigational system adapted for TMS positioning enabled the
relative positions of the figure-8 coil and the target area to be
monitored. Repetitive TMS (110% motor threshold; 1 Hz; 2000 stimuli per
day over 5 days) was performed using a placebo-controlled crossover
design. A sham coil system was used for the placebo stimulation.
Treatment outcome was assessed with a specific tinnitus questionnaire
(Goebel and Hiller).
RESULTS: In all 12 patients an asymmetrically increased metabolic
activation of the gyrus of Heschl was detected. The tinnitus score was
significantly improved after 5 days of active rTMS, an effect not seen
after placebo stimulation.
CONCLUSION: These preliminary results show that neuronavigated rTMS
may improve our understanding and treatment of chronic tinnitus.
Otol Neurotol. 2005 Jul;26(4):616-9.
Transcranial magnetic stimulation for tinnitus: influence of
tinnitus duration on stimulation parameter choice and maximal tinnitus
suppression.
De Ridder D, Verstraeten E, Van der Kelen K, De Mulder G, Sunaert S, Verlooy J, Van de Heyning P, Moller A.
Department of Neurosurgery and Otorhinolaryngology, University Hospital Antwerp, Belgium. dirk.de.ridder@uza.be
OBJECTIVE: Tinnitus is a distressing symptom for which few treatments
exist. It leads to an important decrease in quality of life in 2 to 3%
of the population. Tinnitus is considered a phantom sound, the result of
cortical reorganization. Transcranial magnetic stimulation (TMS) is a
noninvasive method to modulate cortical reorganization and has been
shown to be able to influence tinnitus perception.
STUDY DESIGN: Retrospective analysis. SETTING: Tertiary referral center.
PATIENTS: The effect of TMS of the contralateral auditory cortex in
114 patients with unilateral tinnitus is investigated as one of the
selection criteria used for surgical implantation of electrodes on the
auditory cortex.
INTERVENTION: TMS is performed at 90% of motor threshold at 1, 3, 5,
10, and 20 Hz, with each stimulation session consisting of 200 pulses.
Results were classified as no effect (0-19% improvement), partial effect
(20-79% improvement), and good effect (80-100 suppression).
MAIN OUTCOME MEASURES: TMS had a good effect in 25% of the patients
studied, partial effect in 28% patients, and no effect in 47%.
RESULTS: TMS at 200 pulses is capable of tinnitus suppression for
seconds only. The results were influenced by tinnitus duration: the
longer the tinnitus exists, the lower the stimulation frequency that
yields maximal tinnitus suppression (p < 0.001). The maximal amount
of tinnitus suppression decreases in time (p < 0.01), resulting in a
2% decrease of potential tinnitus suppression per year.
CONCLUSION: TMS of the auditory cortex is capable of modifying
tinnitus perception for a very short time. The maximal amount of
suppression and best stimulation frequency depends on the tinnitus
duration.
Electromagnetic stimulation as a treatment of tinnitus: a pilot study.
Roland NJ, Hughes JB, Daley MB, Cook JA, Jones AS, McCormick MS.
Department of Otolaryngology, Royal Liverpool University Hospital, UK.
This paper reports the results of a study to determine whether pulsed
electromagnetic stimulation, applied over the mastoid bone, caused an
improvement in the level of tinnitus in long-standing tinnitus
sufferers. Fifty-eight patients from the Liverpool Tinnitus Association
volunteered to take part in a double-blind placebo controlled trial.
Active and placebo devices were randomly allocated to these patients on
their first visit. At the end of one week of treatment, each patient
noted whether their tinnitus had completely disappeared, was improved,
unchanged or made worse by the treatment Forty-five per cent of the
patients who completed the trial were improved by the active device, but
only 9% by placebo (P = 0.0013, Mann-Whitney test). We suggest that
electromagnetic stimulation may be an effective treatment in some
tinnitus sufferers.
The effect of the siting of exposure to decimeter-range
electromagnetic waves on the function of the hypophyseal-thyroid and
adrenal systems in viral hepatitis.
[Article in Russian]
Mavrodi? VM.
Abstract
The author studied time course of changes in the thyroid and adrenal
systems as shown by the levels of T3, T4, T3/T4, TTH, hydrocortisone,
ACTH in response to exposure to decimetric microwaves (460 MHz, 30
mW/cm2). The microwaves were directed to the area of hepatic, thyroid,
adrenal projections and combinations thereof. An optimal effect was
achieved at the course exposure of the adrenal projection.
The promotion of the healing process
following musculoskeletal injuries comprises growth factor signalling,
migration, proliferation and apoptosis of cells. If these processes
could be modulated, the healing of tendon tissue may be markedly
enhanced. Here, we report the use of the Somagen™ device, which is
certified for medical use according to European laws. It generates
low-frequency pulsed electromagnetic fields that trigger effects of a
nature that are yet to be determined.
Methods
A 1.5-cm wide, linear scrape was
introduced into patellar tendon fibroblast cultures (N?=?5 donors).
Treatment was carried out every second day. The regimen was applied
three times in total with 30 minutes comprising pulsed electromagnetic
field packages with two fundamental frequencies (10 minutes of 33 Hz,
20 minutes of 7.8 Hz). Control cells remained untreated. All samples
were analyzed for gap closure time, proliferation and apoptosis one week
after induction of the scrape wound.
Results
The mean time for bridging the gap
in the nontreated cells was 5.05?±?0.33 days, and in treated cells, it
took 3.35?±?0.38 days (P <0.001). For cell cultures with
scrape wounds, a mean value for BrdU incorporation of OD?=?0.70?±?0.16
was found. Whereas low-frequency pulsed electromagnetic fields treated
samples showed OD?=?1.58?±?0.24 (P <0.001). However, the percentage of apoptotic cells did not differ between the two groups.
Conclusions
Our data demonstrate that low-frequency pulsed electromagnetic fields emitted by the Somagen™ device influences the in vitro wound healing of patellar tendon fibroblasts and, therefore, possibly increases wound healing potential.Keywords: wound healing, proliferation, apoptosis, low-frequency pulsed electromagnetic fields
Background
One of the most important advances in
promotion of the healing process following musculoskeletal injuries has
evolved from the insight that treatment of these injuries with prolonged
immobilization may delay recovery and adversely affect normal tissues.
Conversely, controlled early resumption of activity can promote
restoration of function. Experimental studies in the several past
decades confirm and help explain the deleterious effects of prolonged
immobilization and the beneficial effects of activity on the
musculoskeletal tissues [1,2].
At the beginning of the healing process, controlled motion and loading
of tendon and ligament repair tissue help align the regeneration of
cells and collagen fibers, stimulate collagen synthesis and increase
strength [3–6].
Early or excessive strain, however, can increase the inflammatory
reaction and may damage repair tissue, leading to failure of the healing
process [7].
However, not only mechanical loading or growth factor
signalling is important for healing processes. DNA activity concerning
transcription and translation, as well as cell cycle mechanisms, plays a
pivotal role. Those activities comprise proliferation, migration and
apoptosis of cells. If these processes could be modulated, the healing
of tendon tissue may be enhanced markedly. This modulation could prevent
the occurrence of excessive strain by accelerating tendon healing.
In order to study such processes in vitro,
wound-healing assays have been carried out in tissue cultures for many
years. These assays monitored cell behavior, including appraising the
migration and proliferative capacities of different cells under various
culture conditions. They generally involve growing cells to a confluent
monolayer as a first step. The layer is ‘wounded’ by a scraping device
(razor-blade, pipette tip, needle or cell-scraper). This penning in the
cell layer gets repopulated because the cells on the wound edge are no
longer contact-inhibited. At the cellular level, healing involves the
cells’ detachment from and attachment to the matrix adjacent to the
wound area, migration, and proliferation. This repopulation is
microscopically observed over a time course to assess the gap closure
time, the occupied area over time, or the rate of migration [8–10].
Moreover, proliferation and apoptosis are investigated regularly.
Depending on the cell type, the growth factors present, and the extent
of the wounded region, wound repair ranges from several hours to days.
Until the 1980s it was believed that biological information
within cell systems was being transferred not only chemically but also
physically via electromagnetic waves. Information of this nature
activates or inhibits biochemical processes [11,12].
Led by these findings in the early 1990s, Sachtleben GmbH,
Hamburg, Germany developed the Somagen™ device, which supposedly
stimulates the communication mechanisms of cells (Figure 1).
The low-frequency pulsed electromagnetic fields (PEMF) electromagnetic
signals have been described as affecting enzymes, cells, tissues and
whole organisms. Even though the effects exerted by PEMF could be
measured, the reasons for the reactions of the biological systems remain
unidentified. However, several theories exist to explain these effects,
for example the Larmor precession [13,14], the hypothesis of Gartzke and Lange [15] or radical pair mechanism [16–18] (for review see [19]). The application of the PEMF induces changes in cellular processes, among others, differentiation [20], apoptosis [21], DNA synthesis [22], protein expression [23], protein phosphorylation [24], anti-inflammatory effects [25] and hormone production [26].
Figure 1The low-frequency pulsed electromagnetic fields (PEMF) emitting Somagen™ device.
In this work, a specific ‘wound healing’ program lasting 30 minutes was
used. The applied program consisted of two PEMF signal packages of …
PEMF instruments like the Somagen™ device generate
low-frequency electromagnetic signals in order to accelerate, among
others, wound healing response. This enhances the regeneration potential
of the destroyed tissue, especially the stimulation of new formation of
connective tissue, something for which the vasodilatation and increased
cell division are likely responsible [27].
Furthermore, growth factor signalling, which is important for healing
processes, can be influenced by low-frequency electromagnetic signals.
Zhao et al. could demonstrate a stimulation of the VEGF
receptor signaling pathway by applying an electric field on vascular
endothelial cells [28]. Another study demonstrated an increased type I collagen expression in fibroblasts after exposure to pulsing electric fields [29]. Zhao et al.
summarized that electric fields polarize the activation of multiple
signalling pathways, including the PI3 kinases/Pten, membrane growth
factor receptors and integrins, both key players in the wound healing
processes [30].
However, the effect of low-frequency PEMF
emitted by the Somagen™ device on fibroblasts as key players in wound
healing remains to be investigated. Therefore, this study focuses on the
effects of PEMF on the healing process of tendon fibroblasts in an in vitro
wound healing model. Our findings may be helpful in the field of
ligament tissue engineering and may support the development of new
strategies for ligament repair.
Methods
Cell culture
Fibroblasts were isolated from five
patients undergoing surgical treatment of the knee joint. The study
protocol is in accordance with the standards of the Declaration of
Helsinki. Following approval by the ethical committee of Hannover
Medical School, written informed consent was obtained from the patients.
The specimens of approximately 4?×?2 mm were aseptically collected from
the patellar tendon. The obtained patellar tendon specimen was divided
into 0.5 mm2 pieces and transferred into petri dishes with a
roughened bottom. Dulbecco’s Modified Eagle’s Medium (DMEM) was used as
culture medium containing 10% fetal calf serum, 1% gentamicin and 1%
amphotericin B (Biochrom, Berlin, Germany). Tissue specimens were
cultured in a humidified environment with 5% CO2 at 37°C.
Medium was replenished every second day. After six to eight days,
fibroblasts started to grow out of the patellar tendon specimens. After
another three to four weeks, the cells reached 80 to 90% confluence. The
cells were trypsinized and subcultured in 75 cm2 flasks (13?×?103 cells/cm2).
Concomitantly, they were counted and an overall viability of more than
90% was observed using the trypan blue exclusion test. This procedure
was repeated once. Cells in the second passage were harvested and
1.5?×?105 fibroblasts were transferred into six-well tissue culture plates (Corning, Vienna, Austria).
Induction of the scrape wound
Scrape wounds were performed in
confluent monolayer cultures of the patellar tendon fibroblasts. A
1.5 cm wide, linear scrape was introduced with a cell scraper over the
entire diameter of the well. The wound area was marked with three black
ink dots on each side of the wound for reference. Cultures were rinsed
with culture medium to remove floating cellular debris, and fresh
culture medium was added.
Cell cultures were treated every second
day, three times in total, with a registered and certified Somagen™
device, according to company’s protocol (Sachtleben GmbH, Hamburg) In
this work, a specific “wound healing” program was used. The applied
program consisted of two PEMF signal packages of 10 minutes at a
fundamental frequency of 33 Hz and 20 minutes at 7.8 Hz. This ‘wound
healing’ program was developed by Sachtleben GmbH in cooperation with
different dermatology clinics and has been successfully used before in a
clinical setting [31].
The signals have the shape of spike pulses with varying send/pause
intervals. Thereby, a magnetic flux density of 0.25 ?T up to 3.16 ?T
emerged. At a 5-mm distance from the applicator, electric field strength
up to 6.3 mV/cm was measurable (Additional file 1).
Applicators attached to the Somagen™ device were placed in the
incubator. The six-well tissue culture dishes were put directly on top
of the applicators, thereby having a distance to the fibroblast
monolayer of approximately 1 to 2 mm. Control cells were also put on the
applicator without starting the program and were cultivated in a
separate incubator to avoid interactions between the stimulated and
nonstimulated cells.
In order to measure any deviation between
the treated versus the control cell cultures, time to closure of the
gap, proliferation and apoptosis were determined.
Time to closure
The wound was microscopically examined daily for repopulation of the wound area (Figure 2A).
The end point of observation was the complete bridging of the scrape
wound. Therefore, before the scratch was initiated, a photograph as
control with a 20× magnification was captured with the microscope
(Zeiss). Afterwards, a photograph with the same magnification was made
every day. For quantification, the free area was highlighted, calculated
and compared to the control with the software ImageJ 1.42q (National
Institute of Health, Maryland, USA). Three independent calculations of
each donor were made.
Figure 2The use of low-frequency pulsed electromagnetic fields (PEMF) lead to a significantly lower time to closure. Scrape wound of patellar tendon fibroblasts caused by a cell scraper (A), magnification 60×. For the analysis of the time to closure, …
Proliferation
The analysis of cell proliferation
was performed one week after induction of the scrape wound using a
standard BrdU kit for spectrophotometry (Roche, Mannheim, Germany). BrdU
is a thymidine analog that is incorporated into the DNA during the
synthesis phase (S1) of the cell cycle. At 0, 6 and 12 hours after
application of BrdU, the amount of inserted BrdU was analyzed according
to a modified protocol for the larger dishes. To remove non-incorporated
BrdU, cells were washed twice with DMEM. Washed cells were fixed with
70% ethanol in 0.5 M HCl at -20°C for 30 min and washed three more times
with DMEM. Nucleases were added to the cells at 37°C for 30 min to
increase the accessibility of the incorporated BrdU for detection by
anti-BrdU Fab-fragment. This incubation was performed in a buffer
containing 66 mM Tris, 0.66 mM MgCl2, and 1 mM
2-mercaptoethanol to permeate the cells and disintegrate disulphide
bonds. After washing the cells three times with DMEM, a mouse monoclonal
Fab-fragment against BrdU conjugated with horse-radish peroxidase was
added to the cells together with 10 mg/ml BSA in phosphate-buffered
saline. The cells were incubated at 37°C for 30 min and subsequently
washed three times with DMEM. The bound conjugate was visualized using
1 mg/ml of the soluble chromogenic substrate 2,2′-Acinobis
[3-ethylbenzthiazoline-sulfonic acid] (ABTS). The signal was increased
by adding 1 mg/ml of ABTS-substrate enhancer. The optical density of
each sample was measured at 405 nm and 490 nm.
Apoptosis rate
Analysis of apoptosis was performed
one week after induction of the scrape wound according to the protocol
provided by the manufacturer (Bender Med systems, Vienna, Austria).
Briefly, adherent cells were detached from the cell culture dishes by
carefully scratching with a cell scraper. The cells were centrifuged at
1500?×?g and 4°C; afterwards, the pellet was carefully resuspended in
100 ?l binding buffer (10 mM HEPES, pH 7.4; 140 mM NaCl; 5 mM CaCl2)
and stained with 6 ?l recombinant human annexin-V-FITC and 6 ?l of
propidium iodide for discrimination of living, apoptotic and necrotic
cells (Bender Med Systems, Vienna, Austria). After incubation for 20 min
at 4°C in darkness, the cells were centrifuged and resuspended in
100 ?l binding buffer. Flow cytometry was carried out on a FACS-calibur
(Becton-Dickinson, Heidelberg, Germany). The software Cellquest-pro V1.1
from Becton-Dickinson was used for data analysis.
Statistical analysis
All experiments were performed in
duplicates for each of the five patients. Furthermore, cells of each
donor were divided into two groups: treated and nontreated. Data are
presented as mean?±?standard deviation. Differences between the treated
and nontreated patellar tendon fibroblasts were analyzed using Student’s
t-test. A P value of less than 0.05 was considered statistically significant.
Results
Characterization of the patellar tendon fibroblasts
Patellar tendon fibroblasts were used for cell culture. Characterization of the cells was carried out as described before [32].
Time to closure
A uniform 1.5-cm-wide scrape wound
was observed in every well of the six-well tissue culture plates. The
edges of the wounds were sharply delineated. Damaged cells were observed
in the edges that still adhered to the bottom of the well. On the
consecutive days, the wound area was occupied by fibroblasts. The mean
time for bridging the gap in the nontreated cells was 5.05?±?0.33 days
(Figure 2B).
Treatment with the specific ‘wound healing’ program emitted by Somagen™
device significantly accelerated the bridging time to 3.35?±?0.38 days (P <0.001).
Apoptosis rate
The percentage of Annexin-V positive
cells did not differ between the two groups (nontreated 38.5?±?6.5%
versus Somagen™ device-treated 38.7?±?7.7%) as depicted in Figure 3A.
Figure 3The low-frequency pulsed electromagnetic fields (PEMF) did
not affect the apoptotic rate but significantly increased the
proliferation. Apoptosis level in patellar tendon fibroblasts in the scrape wound after 1 week (B). Apoptosis was measured …
Proliferation
Proliferation was determined by
BrdU incorporation. The obtained values are optical density values
corrected for unspecific backgrounds (Figure 3B).
Untreated cell cultures with scrape wounds showed a mean value of
0.70?±?0.16. A significant increase was observed after application of
the specific ‘wound healing’ program emitted by Somagen™ device
(1.58?±?0.24, P <0.001).
Discussion
We investigated that certain low-frequency PEMF sequences influence in vitro
wound healing of patellar tendon fibroblasts possibly via increasing
the proliferation rate. In a similar model of scrape wounding of human
foreskin fibroblasts, the 0.8-mm-wide gap was closed within 36 hours due
to a preassembled matrix-containing fibrinogen. Moreover, this
accelerated closure of the gap was associated with an 8-fold increase in
3H-thymidine incorporation, indicating a high proliferation rate [10]. Rodemann et al.,
who treated skin fibroblasts with electromagnetic fields, could detect a
significant increase of the collagen synthesis and the protein content [33].
The proliferation capacity of the cells probably plays a role in the
secondary wound healing phase. As noted in similar models using
intestinal epithelial cells or endothelial cells, the rate of cell
proliferation, determined by BrdU incorporation, did not differ between
migrating and stationary cells over the initial 24-h period [34–36].
This indicates that early epithelial and endothelial restitution is
independent of proliferation. After the migration phase that allows
cells to go beyond the wound edges, cells have to proliferate in order
to repopulate the wound area.
These processes are modulated by signal transduction pathways. The second messenger Ca2+ seems to be involved, as brief treatment with increased extracellular Ca2+ during scrape wounding accelerated wound area closure rates by 50% [37,38].
In our study, the tendon fibroblasts display 30% better wound area
closure rates by low-frequency PEMF treatment. The differences may be
due to the different cell origin, namely skin fibroblasts in the
literature and tendon fibroblasts in our study. Furthermore, the
multi-functional signal transducer NF-?B was activated as soon as
30 minutes after scrape wounding [35].
Especially at the wound edges, the subunit p65 was found. Within
5 minutes after wounding, ERK activation was evident. Again, this
activation was particularly prominent in cells residing at the scrape
edge [9].
These signal transduction molecules are important during adaptation and
healing processes of tendon fibroblasts. This has been observed using
cyclic, longitudinal strain in patellar tendon fibroblasts. Fifteen
minutes of strain elicit NF-?B binding to DNA and is associated with
increased proliferation [39,40]. c-fos and JNK are also activated [41]. Therefore, low-frequency PEMF may activate these signal transduction pathways.
These signal transduction pathways are not only involved
in proliferation but also in apoptosis. In our model, 30 to 40%
apoptosis of patellar tendon fibroblasts was observed. This is in
concert with earlier observations using the same type of cells [41].
Treatment with the specific ‘wound healing’ low-frequency PEMF program
did not result in any changes in apoptosis rates. Epithelial cells
showed induction of apoptosis originating at the wound edges, but this
apoptotic effect subsequently spread over a 24-hour period to encompass
areas not originally damaged [42].
Our study included only five replicates; therefore, more
studies are necessary to further investigate the positive effect of
low-frequency PEMF in a larger cohort of samples. Additionally, in vivo studies should confirm these results in a whole organism with tendon pathology.
Nevertheless, the treatment with low-frequency PEMF enhances the wound healing potential of patellar tendon fibroblasts in vitro.
The incidence of tendon and ligament injuries grows due to the
increasingly sports-oriented society. Treatment of such injuries is
still a challenge to orthopedic trauma surgeons as a restitutio ad integrim
can hardly be achieved. Therefore, new modes of treatment are
investigated to improve the outcome of such pathologies. Low-frequency
PEMF seems to have no adverse effects when applied in the human
situation [31]. Furthermore, it is non-invasive, easy to handle, and has a short application time.
Conclusions
These results may be extrapolated
to wound-healing phenomena in other soft tissues, for example skin and
muscle. Wound healing is a complex process involving many different cell
types and coordinated signalling responses, but fibroblasts, as a part
of this complexity, support the healing process and in our study show an
improved wound area closure rate under the influence of low-frequency
PEMF. Thus, low-frequency electromagnetic signals could be an
interesting new treatment option for wound-healing processes in vivo by accelerating closure of the wounds. Based on the positive results, further in vivo studies using low-frequency PEMF generated by the Somagen™ device for modulating wound healing
The authors declare that they have
no competing interests. Sachtleben GmbH provided the Somagen™ device for
this project free of charge. Jens Sachtleben and Karsten Falldorf are
both managing directors of Sachtleben GmbH.
Authors’ contributions
CS and MvG conceived and designed
the study. CS and MvG performed the experiments and analyzed the data.
KF and JS provided data on the device and reviewed the manuscript. All
authors read and approved the final manuscript.
The authors would sincerely like to
thank Sachtleben GmbH for providing the Somagen™ device for this
project. We would also like to thank Fritz Seidl, M.A. Interpreting and
Translating, for proofreading this paper.
References
Khan KM, Scott A. Mechanotherapy: how physical therapists’ prescription of exercise promotes tissue repair. Br J Sports Med. 2009;43:247–252. [PMC free article] [PubMed]
Szczesny SE, Lee CS, Soslowsky LJ. Remodeling and repair of orthopedic tissue: role of mechanical loading and biologics. Am J Orthop (Belle Mead NJ) 2010;39:525–530. [PubMed]
Bedi A, Kovacevic D, Fox AJ,
Imhauser CW, Stasiak M, Packer J, Brophy RH, Deng XH, Rodeo SA. Effect
of early and delayed mechanical loading on tendon-to-bone healing after
anterior cruciate ligament reconstruction. J Bone Joint Surg Am. 2010;92:2387–2401. [PMC free article] [PubMed]
Maganaris CN, Narici MV,
Almekinders LC, Maffulli N. Biomechanics and pathophysiology of overuse
tendon injuries: ideas on insertional tendinopathy. Sports Med. 2004;34:1005–1017. [PubMed]
Peltz CD, Dourte LM, Kuntz AF,
Sarver JJ, Kim SY, Williams GR, Soslowsky LJ. The effect of
postoperative passive motion on rotator cuff healing in a rat model. J Bone Joint Surg Am. 2009;91:2421–2429. [PMC free article] [PubMed]
Thomopoulos S, Zampiakis E, Das
R, Silva MJ, Gelberman RH. The effect of muscle loading on flexor
tendon-to-bone healing in a canine model. J Orthop Res. 2008;26:1611–1617. [PMC free article] [PubMed]
Schlegel TF, Faber KJ, Chen AL,
Hawkins RJ. The effect of postoperative immobilization on the healing
of radiofrequency heat probe modified tissue: assessment of tissue
length, stiffness, and morphology. Orthopedics. 2008;31:134. [PubMed]
Desai RA, Gao L, Raghavan S, Liu WF, Chen CS. Cell polarity triggered by cell-cell adhesion via E-cadherin. J Cell Sci. 2009;122:905–911. [PMC free article] [PubMed]
Providence KM, Higgins PJ.
PAI-1 expression is required for epithelial cell migration in two
distinct phases of in vitro wound repair. J Cell Physiol. 2004;200:297–308. [PubMed]
Rybarczyk BJ, Lawrence SO,
Simpson-Haidaris PJ. Matrix-fibrinogen enhances wound closure by
increasing both cell proliferation and migration. Blood. 2003;102:4035–4043. [PubMed]
Omura Y. Transmission of
molecular information through electro-magnetic waves with different
frequencies and its application to non-invasive diagnosis of patients as
well as detection from patient’s X-ray film of visible and not visible
medical information: part I. Acupunct Electrother Res. 1994;19:39–63. [PubMed]
Hensel K, Mienkina MP, Schmitz
G. Analysis of ultrasound fields in cell culture wells for in vitro
ultrasound therapy experiments. Ultrasound Med Biol. 2011;37:2105–2115. [PubMed]
Edmonds DT. Larmor precession as a mechanism for the detection of static and alternating magnetic fields. Bioelectrochem Bioenerg. 1993;30:3–12.
Muehsam DJ, Pilla AA. Lorentz
approach to static magnetic field effects on bound-ion dynamics and
binding kinetics: thermal noise considerations. Bioelectromagnetics. 1996;17:89–99. [PubMed]
Gartzke J, Lange K. Cellular target of weak magnetic fields: ionic conduction along actin filaments of microvilli. Am J Physiol Cell Physiol. 2002;283:C1333–C1346. [PubMed]
Tilla U, Timmela CR,
Brocklehurstb B, Horea PJ. The influence of very small magnetic fields
on radical recombination reactions in the limit of slow recombination. Chemical Physics Letters. 1998;298:7–14.
McLauchlan KA, Steiner UE. The spin-correlated radical pair as a reaction intermediate. Mol Phys. 1991;73:241–263.
Timmela CR, Tilla U,
Brocklehurstb B, Mclauchlana KA, Horea PJ. Effects of weak magnetic
fields on free radical recombination reactions. Mol Phys. 1991;95:71–89.
Funk RH, Monsees T, Ozkucur N. Electromagnetic effects – From cell biology to medicine. Prog Histochem Cytochem. 2009;43:177–264. [PubMed]
Ventura C, Maioli M, Asara Y,
Santoni D, Mesirca P, Remondini D, Bersani F. Turning on stem cell
cardiogenesis with extremely low frequency magnetic fields. FASEB J. 2005;19:155–157. [PubMed]
Tofani S, Barone D, Cintorino
M, de Santi MM, Ferrara A, Orlassino R, Ossola P, Peroglio F, Rolfo K,
Ronchetto F. Static and ELF magnetic fields induce tumor growth
inhibition and apoptosis. Bioelectromagnetics. 2001;22:419–428. [PubMed]
Takahashi K, Kaneko I, Date M,
Fukada E. Effect of pulsing electromagnetic fields on DNA synthesis in
mammalian cells in culture. Experientia. 1986;42:185–186. [PubMed]
Goodman R, Henderson AS. Exposure of salivary gland cells to low-frequency electromagnetic fields alters polypeptide synthesis. Proc Natl Acad Sci U S A. 1988;85:3928–3932. [PMC free article] [PubMed]
Sun WJ, Chiang H, Fu YT, Yu
YN, Xie HY, Lu DY. Exposure to 50 hz electromagnetic fields induces the
phosphorylation and activity of stress-activated protein kinase in
cultured cells. Electro- and Magnetobiology. 2001;29:415–423.
Selvam R, Ganesan K, Narayana
Raju KV, Gangadharan AC, Manohar BM, Puvanakrishnan R. Low frequency and
low intensity pulsed electromagnetic field exerts its antiinflammatory
effect through restoration of plasma membrane calcium ATPase activity. Life Sci. 2007;80:2403–2410. [PubMed]
Paksy K, Thuróczy G, Forgács
Z, Lázár P, Gaáti I. Influece of sinusoidal 50-hz magnetic field on
cultured human ovarian granulosa cells. Electro- and Magnetobiology. 2000;19:91–97.
Sachtleben J. Report: Basis Of The Cell Information Therapy. Hamburg: Sachtleben GmbH; 2012. Basis of the Cell Information Therapy; pp. 1–3.
Zhao M, Bai H, Wang E,
Forrester JV, McCaig CD. Electrical stimulation directly induces
pre-angiogenic responses in vascular endothelial cells by signaling
through VEGF receptors. J Cell Sci. 2004;117:397–405. [PMC free article] [PubMed]
Chao PH, Lu HH, Hung CT,
Nicoll SB, Bulinski JC. Effects of applied DC electric field on ligament
fibroblast migration and wound healing. Connect Tissue Res. 2007;48:188–197. [PubMed]
Zhao M. Electrical fields in wound healing-An overriding signal that directs cell migration. Semin Cell Dev Biol. 2009;20:674–682. [PubMed]
Visan A. Efficacy and tolerance of cell information therapy (CIT) on wound healing processes free of transplants. Kosmetische Med. 2007;3:112–117.
Bosch U, Zeichen J, Skutek M,
Albers I, van Griensven M, Gassler N. Effect of cyclical stretch on
matrix synthesis of human patellar tendon cells. Unfallchirurg. 2002;105:437–442. [PubMed]
Rodemann HP, Bayreuther K,
Pfleiderer G. The differentiation of normal and transformed human
fibroblasts in vitro is influenced by electromagnetic fields. Exp Cell Res. 1989;182:610–621. [PubMed]
Ciacci C, Lind SE, Podolsky
DK. Transforming growth factor beta regulation of migration in wounded
rat intestinal epithelial monolayers. Gastroenterology. 1993;105:93–101. [PubMed]
Egan LJ, de Lecea A, Lehrman
ED, Myhre GM, Eckmann L, Kagnoff MF. Nuclear factor-kappa B activation
promotes restitution of wounded intestinal epithelial monolayers. Am J Physiol Cell Physiol. 2003;285:C1028–C1035. [PubMed]
Iizuka M, Konno S. Wound healing of intestinal epithelial cells. World J Gastroenterol. 2011;17:2161–2171. [PMC free article] [PubMed]
Milara J, Mata M, Serrano A,
Peiro T, Morcillo EJ, Cortijo J. Extracellular calcium-sensing receptor
mediates human bronchial epithelial wound repair. Biochem Pharmacol. 2010;80:236–246. [PubMed]
Tran PO, Hinman LE, Unger GM,
Sammak PJ. A wound-induced [Ca2+] i increase and its transcriptional
activation of immediate early genes is important in the regulation of
motility. Exp Cell Res. 1999;246:319–326. [PubMed]
van Griensven M, Zeichen J, Skutek M, Bosch U, Tachibana H. In: Tissue engineering in der Orthopädie: Neues zum Gewebeersatz im Muskel-Skelett-System.
Bruns J, editor. Darmstadt: Steinkopf; 2003. Die Aktivierung des
Transkriptionsfaktors NF-kB und des Protoonkogens c-fos in humanen
Fibroblasten nach zyklischer mechanischer Dehnung; pp. 164–173.
Zeichen J, van Griensven M,
Bosch U. The proliferative response of isolated human tendon fibroblasts
to cyclic biaxial mechanical strain. Am J Sports Med. 2000;28:888–892. [PubMed]
Skutek M, van Griensven M,
Zeichen J, Brauer N, Bosch U. Cyclic mechanical stretching of human
patellar tendon fibroblasts: activation of JNK and modulation of
apoptosis. Knee Surg Sports Traumatol Arthrosc. 2003;11:122–129. [PubMed]
Low frequency pulsed electromagnetic field
(PEMF) has proven to be effective in the modulation of bone and
cartilage tissue functional responsiveness, but its effect on tendon
tissue and tendon cells (TCs) is still underinvestigated. PEMF treatment
(1.5 mT, 75 Hz) was assessed on primary TCs, harvested from
semitendinosus and gracilis tendons of
eight patients, under different experimental conditions (4, 8, 12 h).
Quantitative PCR analyses were conducted to identify the possible effect
of PEMF on tendon-specific gene transcription (scleraxis, SCX and type I
collagen, COL1A1); the release of pro- and anti-inflammatory cytokines
and of vascular endothelial growth factor (VEGF) was also assessed. Our
findings show that PEMF exposure is not cytotoxic and is able to
stimulate TCs’ proliferation. The increase of SCX and COL1A1 in
PEMF-treated cells was positively correlated to the treatment length.
The release of anti-inflammatory cytokines in TCs treated with PEMF for 8
and 12 h was significantly higher in comparison with untreated cells,
while the production of pro-inflammatory cytokines was not affected. A
dramatically higher increase of VEGF-A mRNA transcription and of its
related protein was observed after PEMF exposure. Our data demonstrated
that PEMF positively influence, in a dose-dependent manner, the
proliferation, tendon-specific marker expression, and release of
anti-inflammatory cytokines and angiogenic factor in a healthy human TCs
culture model.
Knee Surg Sports Traumatol Arthrosc. 2008 Jun; 16(6): 595–601.
Published online 2008 Apr 2. doi: 10.1007/s00167-008-0519-9
PMCID: PMC2413121
Effects of biophysical stimulation in patients
undergoing arthroscopic reconstruction of anterior cruciate ligament:
prospective, randomized and double blind study
Francesco Benazzo,1 Giacomo Zanon,1 Luigi Pederzini,2 Fulvio Modonesi,2 Carlo Cardile,3 Francesco Falez,4 Luigi Ciolli,4 Filippo La Cava,4 Sandro Giannini,5 Roberto Buda,5 Stefania Setti,
6 Gaetano Caruso,7 and Leo Massari71IRCCS Foundation, Orthopaedic and Traumatology Department, S. Matteo Hospital Institute, University of Pavia, Pavia, Italy
2Orthopaedic Department of Nuovo Ospedale di Sassuolo, Modena, Italy
3Orthopaedic Department of University of Milano – Bicocca, San Gerardo Hospital, Monza, Italy
4Orthopaedic Department of S. Spirito Hospital Institute, Roma, Italy
5Orthopaedic Department of Rizzoli Orthopaedic Institute, Bologna, Italy
6IGEA, Clinical Biophysics, Via Parmenide 10/A, 41012 Carpi (Mo), Italy
7Department of Biomedical Science and Advanced Therapy, University of Ferrara, Ferrara, Italy
Stefania Setti, Phone: +39-059699600, Fax: +39-059695778, Email: moc.lacidemaegi@ittes.s.
Pre-clinical studies have shown that
treatment by pulsed electromagnetic fields (PEMFs) can limit the
catabolic effects of pro-inflammatory cytokines on articular cartilage
and favour the anabolic activity of the chondrocytes. Anterior cruciate
ligament (ACL) reconstruction is usually performed by arthroscopic
procedure that, even if minimally invasive, may elicit an inflammatory
joint reaction detrimental to articular cartilage. In this study the
effect of I-ONE PEMFs treatment in patients undergoing ACL
reconstruction was investigated. The study end-points were (1)
evaluation of patients’ functional recovery by International Knee
Documentation Committee (IKDC) Form; (2) use of non-steroidal
anti-inflammatory drugs (NSAIDs), necessary to control joint pain and
inflammation. The study design was prospective, randomized and double
blind. Sixty-nine patients were included in the study at baseline.
Follow-up visits were scheduled at 30, 60 and 180 days, followed by
2-year follow-up interview. Patients were evaluated by IKDC Form and
were asked to report on the use of NSAIDs. Patients were randomized to
active or placebo treatments; active device generated a magnetic field
of 1.5 mT at 75 Hz. Patients were instructed to use the stimulator
(I-ONE) for 4 h per day for 60 days. All patients underwent ACL
reconstruction with use of quadruple hamstrings semitendinosus and
gracilis technique. At baseline there were no differences in the IKDC
scores between the two groups. At follow-up visits the SF-36 Health
Survey score showed a statistically significant faster recovery in the
group of patients treated with I-ONE stimulator (P < 0.05). NSAIDs use was less frequent among active patients than controls (P < 0.05). Joint swelling resolution and return to normal range of motion occurred faster in the active treated group (P < 0.05)
too. The 2-year follow-up did not shown statistically significant
difference between the two groups. Furthermore for longitudinal analysis
the generalized linear mixed effects model was applied to calculate the
group × time interaction coefficient; this interaction showed a
significant difference (P < 0.0001) between the active and
placebo groups for all investigated variables: SF-36 Health Survey, IKDC
Subjective Knee Evaluation and VAS. Twenty-nine patients (15 in the
active group; 14 in the placebo group) underwent both ACL reconstruction
and meniscectomy; when they were analysed separately the differences in
SF-36 Health Survey scores between the two groups were larger then what
observed in the whole study group (P < 0.05). The results
of this study show that patient’s functional recovery occurs earlier in
the active group. No side effects were observed and the treatment was
well tolerated. The use of I-ONE should always be considered after ACL
reconstruction, particularly in professional athletes, to shorten the
recovery time, to limit joint inflammatory reaction and its catabolic
effects on articular cartilage and ultimately for joint preservation.Keywords: Anterior cruciate ligament, Chondroprotection, Biophysical stimuli, Pulsed electromagnetic fields, Joint preservation
Introduction
Articular cartilage performs mechanical
functions absorbing the different loads applied to a joint in the course
of daily activity [19].
Homeostasis and mechanical competence of cartilage are regulated by the
activity of the chondrocytes that maintain the function and the
integrity of the extracellular matrix, proteoglycans and collagen.
In consideration of the scant repairability of the
cartilage, even modest damages resulting from trauma or inflammation may
be the starting point for cartilage degeneration leading over time to
extensive lesions that deepen into the thickness of the cartilage
itself, ultimately exposing the subchondral bone tissue [3, 17].
Joint injury may involve synovial tissue, cartilage and
subchondral bone leading to joint inflammation, swelling and pain.
Surgical interventions must certainly be included among the triggers of
inflammatory reaction in a joint [12].
The development of arthroscopic procedures has undoubtedly limited
joint damage associated to surgery for reconstruction of ligaments;
nevertheless, it does not avoid the inflammatory response. Thus, while
arthroscopic procedures make surgery less invasive, the inflammatory
response at the joint remains and the release of pro-inflammatory
cytokines in the synovial fluid is associated with an increase in the
aggrecanase activities that lead to a degradation of the cartilage
matrix, and also inhibit proteoglycan synthesis [11, 15, 18].
To prevent cartilage damage, current pharmacological therapies aim to
control the catabolic effects of the pro-inflammatory cytokines and
enhance anabolic activity, proteoglycan synthesis and proliferation of
chondrocytes. Drugs that combine the above effects are called
chondroprotectors; in this category should be included drugs with A2A
adenosine receptor agonist activity, able to stimulate the
physiological pathways that control inflammation and promote chondrocyte
anabolic activities. Nevertheless, these drugs are in early stages of
clinical testing [5].
Pre-clinical studies have shown that pulsed electromagnetic fields (PEMFs) in vitro favour the proliferation of chondrocytes [6, 16], stimulate proteoglycan synthesis [7] and demonstrate an A2A adenosine receptor agonist activity [20, 21].
Electromagnetic fields in vivo prevent degeneration of articular
cartilage and down-regulate the synthesis and release of
pro-inflammatory cytokines in the synovial fluid [2, 4, 8, 9].
These findings suggest that electromagnetic fields may be used to
control joint inflammation and to stimulate cartilage anabolic
activities, finally resulting in chondroprotection.
A clinical study performed in patients undergoing
arthroscopic treatment for cartilage lesions showed that biophysical
treatment with PEMFs was well tolerated by the patients and led to a
decrease in the use of non-steroidal anti-inflammatory drugs (NSAIDs)
and to an early functional recovery; the positive effect of the
treatment was maintained at a 3-year follow-up [22].
Arthroscopic reconstruction is the
treatment of choice following anterior cruciate ligament (ACL) rupture;
although minimally invasive, the procedure is associated with joint
reaction involving the synovia and it is expected to lead to an increase
of pro-inflammatory cytokines in the synovial fluid with catabolic
effect on articular cartilage. In this study, we evaluated whether the
treatment with PEMFs could be used to control joint inflammatory
response in patients undergoing ACL reconstruction. The end points of
the study were: (1) patients’ functional recovery evaluated by
International Knee Documentation Committee (IKDC) form; (2) use of
NSAIDs, necessary to control joint pain and inflammation.
Materials and methods
Patients and study design
In 2004–2005, 84 patients undergoing ACL
reconstruction were evaluated for inclusion in the study at five
clinical centres. Of these, 69 gave their informed consent to
participate in the study. The prospective randomized and double-blind
study was approved by the local ethical committees. Inclusion criteria
were the following: age between 18 and 45 years, ACL complete lesion
following acute trauma or consequence of ligament chronic degeneration.
All lesions were documented by MRI and confirmed during the
intervention. The following were the exclusion criteria: osteonecrosis
of the femoral condyle, rheumatoid arthritis, autoimmune disease,
systemic disease and patients requiring meniscus repair.
The patients were assigned to the active or placebo group
according to the following randomization criteria: age (18–30 or 31–45),
sex, smoking status, origin of ACL rupture (traumatic or degenerative).
For randomization of patients, a computer-generated schedule was
prepared by a biostatistician. In this process, a random number seed was
entered into the computer to generate a list that assigned equal
numbers of active and placebo stimulators. The minimum number of
patients per group required was calculated by power analysis taking into
account the results of a previous study [22].
Of the 69 patients included, two never
started the therapy, two dropped out within 2 weeks of therapy, and five
did not return at follow-up visits; a total of 60 patients were
therefore available for subsequent analysis. The ACL rupture occurred
during sports activity in 49 patients (24 active and 25 placebo), daily
activity in eight patients (four active and four placebo) and traffic
accident in three patients (three active). At the time of ACL
reconstruction 29 patients underwent also meniscectomy: 15 in the active
group and 14 in the placebo.
Clinical evaluation
The patients were evaluated by IKDC Form
before the intervention and at 30, 60 and 180 days afterwards. The
different parts of the questionnaire, IKDC Current Health Assessment
Form (SF-36 Health Survey), IKDC Subjective Knee Evaluation Form and
IKDC Knee Examination Form were analysed separately. As regards the
scores of the questionnaires, for each subject we considered the changes
at follow-up visits with respect to the values recorded at baseline,
before surgery.
Pain intensity was evaluated by visual analogue scale
(VAS) of 10-cm length: 0 cm no pain, 10 cm maximum pain. The patients
were allowed to use NSAIDs to control knee pain when present and had to
report doing so.
A 2-year follow-up telephone interview
was conducted and the patients were asked: (a) if they had undergone
further surgery at the knee, (b) if they had pain at the knee, (c) if
they had functional limitation in daily activity, (d) if they returned
to previous sport activity level.
Surgical technique
ACL arthroscopic repair was
performed by quadruple hamstrings semitendinosus and gracilis technique.
Tendons were harvested with the tendons stripper through a 2–3 cm
vertical incision on the antero-medial tibial area. Diameter of the
quadruple hamstrings semitendinosus and gracilis tendons was measured,
while the tibial tunnel and same size femoral tunnel (30 mm length) were
prepared. The graft was pulled up through the tibial tunnel with the
knee at 90° of flexion and suspended on the external femoral cortex
(Endobutton, Smith and Nephew, London, UK). Distally, the graft was
fixed with an interference absorbable screw at the tibia at 10° of
flexion.
Rehabilitation
All the patients underwent standard
rehabilitation using passive knee flexion daily. Exercises started
within the third post-operative day with isometric quadriceps
contractions and then progressed to active closed-chain exercises by
4–6 weeks postoperatively. During the first 20 days patients were
instructed to use two crutches and then progressive weight bearing until
the end of the second month.
Biophysical stimulation
The patients were treated with active or
placebo devices. The active stimulators (I-ONE; IGEA, Carpi, Italy)
generated a magnetic field of peak intensity of 1.5 mT at a frequency of
75 Hz; no heat or vibration was felt by the patient during treatment
(Fig. 1).
Fig. 1Left I-ONE PEMFs generator. Right wave form of magnetic field, 1.5 mT peak value (top); electric field induced in a standard coil probe made of 50 turns (0.5 cm ?) of copper wire (0.2 mm ?), peak value 3 mV/cm …
The patients were instructed to use the
stimulator for 4 h per day, not necessarily consecutively, for 60 days.
Treatment started within 7 days from the surgery. Each device contained a
clock to monitor the hours of use.
Statistical analysis
The results were analysed with SPSS 13.0
(Statistical Packages for Social Sciences Inc, Chicago, IL, USA).
Comparison among the continuous variables in the two groups was
performed with Student’s heteroschedastic t test; comparison of continuous variables within each group during follow-up was performed with Student’s paired t test.
Binomial and categorical variables were compared by
contingency tables applying the chi-square test for 2 × 2 tables and the
Cochran Mantel Haenszel test for larger size tables.
Generalized linear mixed effects model was applied to the
SF-36 Health Survey, IKDC Subjective Knee Evaluation and VAS data to
test if a different trend between the two groups was present during
follow-up by correcting for the following covariates: sex, age, weight,
height, hours of treatment, smoking status, use of NSAIDs. In this
analysis, a mathematical model is built which takes into account the
trend over time of individual patients belonging to each group
(Group × Time interaction) and determines if a statistical difference
exists between the groups during the follow-up [10].
The minimum significance level for all the statistical tests was set at P < 0.05.
Results
At baseline, the two groups of study
were homogeneous for age, weight, height, VAS, SF-36 Health Survey and
IKDC Subjective Knee Evaluation score (Table 1).
Average daily treatment was the same in both groups:
3.92 ± 0.5 h/die versus 3.13 ± 0.3 h/die in the I-ONE group and the
placebo group, respectively (P = n.s.).
The average pain was modest and almost absent at 6 months’
follow-up: 0.7 ± 0.2 cm among placebo and 0.9 ± 0.2 cm among active. At
30 days, less patients in the active group used NSAIDs: 8% in the I-ONE
group versus 27% in the placebo group (P < 0.05).
The SF-36 Health Survey score decreased significantly at 30 days, in both groups (P < 0.0005).
At 60 days the mean SF-36 Health Survey score in the I-ONE patients
already exceeded the initial value (by 3.2 points), whereas in the
patients of the placebo group SF-36 Health Survey score was slightly
below the initial mean value (by ?0.7 units). At 6 months a significant (P < 0.005)
increase was observed for SF-36 Health Survey average values in both
groups; the patients of the I-ONE group were above the initial values by
10.1 units, while the placebo group exceeds the baseline value by 7.2
units. The mean changes of SF-36 Health Survey score in the I-ONE group
are systematically higher with respect to placebo during follow-up, P < 0.05 (Fig. 2).
Fig. 2
Mean changes of SF-36 Health Survey (±SE) versus baseline in the two groups (P < 0.05)
The IKDC Subjective Knee Evaluation score increased over
6 months and did not show significant differences between the two groups
at any follow-up visit.
The IKDC Knee Examination Form outlined both groups
including subjects with joint swelling before surgery (one in placebo
and two in I-ONE group, P = n.s.) and at 30 days’ follow-up (five in placebo and six in I-ONE group, P = n.s.).
On day 60, joint swelling was observed in the placebo group (two
patients) only. Joint swelling was not observed any more at 6 months’
follow-up. Limitation in the passive range of motion of the knee was
more frequent in the placebo group than in the I-ONE group (P < 0.05) (Fig. 3).
Fig. 3
Patients with limitation in passive range of motion in the two groups, P < 0.05
Finally, the generalized linear mixed effects analysis revealed a significantly different trend (group × time interaction, P < 0.0001)
between the two groups for SF-36 Health Survey score, IKDC Subjective
Knee Evaluation score and for VAS, showing a positive effect of I-ONE
treatment. The estimate coefficients and significance of independent
variables for three models are displayed in Table 2.
Table 2
Generalized linear mixed effects models in which the dependent
variables considered are: SF-36 Health Survey score, IKDC Subjective
Knee Evaluation score and VAS, respectively
At the 2-year follow-up interview 86% of the
patients in the I-ONE group and 75% in the placebo group reported
complete functional recovery, no knee pain and return to sport activity.
ACL reconstruction and meniscectomy
When the cohort of patients, undergoing
both ACL reconstruction and meniscectomy, was analysed separately, the
SF-36 Health Survey score confirmed the faster recovery trend among
I-ONE treated patients compared to placebo, P < 0.05 (Fig. 4). At 6 months, SF-36 Health Survey average score increase was 11.4 in the I-ONE group (P < 0.005 vs. baseline) and 7.1 in placebo group (P = ns
vs. baseline). Further, the average values of SF-36 Health Survey were
significantly higher in the I-ONE group compared to the placebo
(45.2 ± 1.5 vs. 37 ± 2.7, P < 0.05).
Fig. 4
Patients undergoing ACL and meniscectomy: mean changes of SF-36 Health Survey (±SE) versus baseline in the two groups (P < 0.05)
The percent of patients with limitation
in the passive range of motion was lower in the I-ONE group compared to
the placebo one (34% I-ONE vs. 50% placebo at day 30 and 4% I-ONE vs.
17% placebo at day 60, P < 0.05).
Discussion
Arthroscopic surgery has gained a large
success and led to a significant increase in its use: about 650,000
procedures are performed in the USA each year [14].
However, the access into the joint space is always associated to an
inflammatory reaction that may jeopardize the benefits expected from
surgery. Joint inflammation has a catabolic effect on extracellular
matrix and inhibits chondrocyte activity; thus, all means capable of
locally controlling the inflammation should be adopted to prevent the
onset and limit the progression of cartilage damage. Furthermore, unlike
bone tissue after damage, the cartilage will not completely recover its
competence: once lost, the articular cartilage does not reform [13].
Many efforts are made to develop strategies able to
control joint inflammation and to favour the anabolic activities of
chondrocytes; these are challenging objectives, and up to now the
pharmacological approaches based on the use of drugs, whether by
systemic or by local route, have not yet been able to demonstrate a
genuine chondroprotective effect in humans [19].
Pre-clinical studies have shown PEMFs to have a
chondroprotective effect, mediated by the control of inflammation and by
the stimulation of chondrocyte activity; thus, we hypothesized that
after arthroscopic surgery PEMFs treatment can be used for articular
cartilage protection and ultimately joint preservation.
This prospective, randomized and double-blind study
investigated whether and to what extent the employment of I-ONE, by
controlling joint reaction to arthroscopy, could accelerate functional
recovery in patients undergoing ACL reconstruction. The I-ONE treatment
was well tolerated by the patients and no adverse side effects were
observed. The results show that, at 30 days after surgery, in I-ONE
group significantly fewer patients used NSAIDs to control pain, compared
to patients in the placebo group; afterwards, the use of NSAIDs was not
necessary in either group.
When IKDC Subjective Knee Evaluation average scores were
analysed, we found no statistically significant difference between the
I-ONE and placebo group; this is in agreement with the findings of other
authors who reported that this parameter does not correlate with the
other clinical information collected using the SF-36 Health Survey form [1].
However, when the results of the two groups were analysed by
generalized linear mixed effects model, which takes into account the
trend of each patient in both groups and the effect of confounding
factors, we could evidence a positive significant effect of I-ONE
treatment also in the Subjective Knee Evaluation (Table 2).
The SF-36 Health Survey average scores at baseline were
the same in the I-ONE and placebo groups; however, the high standard
deviation testify the large distribution of initial score values. To
monitor patient’s recovery after ACL reconstruction, we considered the
SF-36 Health Survey score changes with respect to baseline for each
individual subject. At 2 and 6 months SF-36 Health Survey increase is
undoubtedly higher in I-ONE group than in the placebo group. This result
indicates a faster recovery in the treated patients. This positive
effect of I-ONE treatment is confirmed by the generalized linear mixed
effects analysis. Further, when the cohort of patients who underwent
both ACL reconstruction and meniscectomy was analysed, we observed that
the average increase of SF-36 Health Survey at 60 days in the I-ONE
group was the same as that of placebo group at 6 months (6.0 vs. 7.1, P = n.s.).
The IKDC Knee Examination Form showed how in the placebo
group the resolution of joint swelling and the recovery of complete
range of motion occur later compared to the I-ONE group; no significant
difference in scoring was observed among centres.
The study end-points were thus demonstrated: fewer
patients in the I-ONE group required the use of NSAIDs and their
functional recovery was faster.
At 2-year follow-up no statistically significant
difference was observed between two groups, although the percent of
patients with complete recovery was slightly higher in the I-ONE group.
In this study we applied a statistical analysis
specifically developed for longitudinal studies that allows to calculate
the group × time interaction. This test, that considers individual
patient’s score at different time points and the possible influence of
confounding factors, supports the positive effect of I-ONE treatment on
the recovery of patients undergoing ACL reconstruction.
Our data confirm the results reported by Zorzi et al. [22]
in a group of patients treated with I-ONE following an arthroscopic
treatment for cartilage lesions. To the authors’ knowledge, there are no
other reports of use of biophysical stimulation after surgical
procedures of the knee.
Biophysical stimulation allows treating individual joints,
permeating the whole cartilage surface and thickness, the synovia and
the subchondral bone. The effectiveness of biophysical stimulation is
not limited by considerations such as diffusion ability and
concentration gradient, which are present and important in the dynamic
of a pharmacological intervention; joint tissues are paramagnetic, they
do not attenuate the biophysical signal and thus are all homogenously
exposed to the treatment efficacy. Biophysical stimulation is an
effective therapeutic intervention to control the detrimental
consequences of the inflammation over articular cartilage in the absence
of negative side effects.
I-ONE should always be considered after
ACL reconstruction, particularly in professional athletes, to shorten
the recovery time, to limit joint inflammatory reaction and ultimately
for joint preservation.
Acknowledgments
Supported by Igea through a grant of Research funding of
Regione Emilia Romagna. Setti is Igea employ; the other authors have no
conflict of interest.
Open Access This article is distributed
under the terms of the Creative Commons Attribution Noncommercial
License which permits any noncommercial use, distribution, and
reproduction in any medium, provided the original author(s) and source
are credited.
References
1. Aglietti
P, Giron F, Buzzi R, Biddau F, Sasso F (2004) Anterior cruciate
ligament reconstruction: bone-patellar tendon-bone compared with double
semitendinosus and gracilis tendon grafts. A prospective, randomized
clinical trial. J Bone Joint Surg Am 86(10):2143–2155 [PubMed]
2. Benazzo
F, Cadossi M, Cavani F, Fini M, Giavaresi G, Setti S, Cadossi R,
Giardino R (2008) Cartilage repair with osteochondral autografts in
sheep: Effect of biophysical stimulation with pulsed electromagnetic
fields. J Orthop Res [Epub ahead of print] [PubMed]
3. Buckwalter JA, Mankin HJ (1997) Articular cartilage: part I–II. J Bone Joint Surg 79(4):600–632
4. Ciombor
DM, Aaron RK, Wang S, Simon B (2003) Modification of osteoarthritis by
pulsed electromagnetic field—a morphological study. Osteoarthr Cartil
11(6):455–462 [PubMed]
5. Cohen
SB, Gill SS, Baer GS, Leo BM, Scheld WM, Diduch DR (2004) Reducing
joint destruction due to septic arthrosis usingan adenosine2A receptor
agonist. J Orthop Res 22:427–435 [PubMed]
6. De
Mattei M, Caruso A, Pezzetti F, Pellati A, Stabellini G, Sollazzo V,
Traina GC (2001) Effects of pulsed electromagnetic fields on human
articular chondrocyte proliferation. Connect Tissue Res 42(4):269–279 [PubMed]
7. De
Mattei M, Fini M, Setti S, Ongaro A, Gemmati D, Stabellini G, Pellati
A, Caruso A (2003) Effects of electromagnetic fields on proteoglycan
metabolism of bovine articular cartilage explants. Connect Tissue Res
44:154–159 [PubMed]
8. Fini
M, Giavaresi G, Torricelli P, Cavani F, Setti S, Cane V, Giardino R
(2005) Pulsed electromagnetic fields reduce knee osteoarthritic lesion
progression in the aged Dunkin Hartley guinea pig. J Orthop Res
23(4):899–908 [PubMed]
9. Fini
M, Torricelli P, Giavaresi G, Aldini NN, Cavani F, Setti S, Nicolini A,
Carpi A (2007) Effect of pulsed electromagnetic field stimulation on
knee cartilage, subchondral and epyphiseal trabecular bone of aged
Dunkin Hartley guinea pigs. Biomed Pharmacother [PubMed]
10. Fitzmaurice
GM, Laird NM, Ware JH (2004) Generalized linear mixed effects models.
In: Balding DJ, Cressie NAC, Fisher NI, Johnstone IM, Kadane JB,
Molenberghs G, Ryan LM, Scott DW, Smith AFM, Teugels JL, Barnett V,
Hunter JS, Kendall DG (eds) Applied longitudinal analysis. Wiley,
Hoboken, pp 325–358
11. Goldring
SR, Goldring MB (2004) The role of cytokines in cartilage matrix
degeneration in osteoarthritis. Clin Orthop Relat Res 427:S27–S36
(Review) [PubMed]
12. Green
DM, Noble PC, Bocell JR Jr, Ahuero JS, Poteet BA, Birdsall HH (2006)
Effect of early full weight-bearing after joint injury on inflammation
and cartilage degradation. J Bone Joint Surg Am 88(10):2201–2209 [PubMed]
13. Hunter W (1743) Of the structure and diseases of the articular cartilages. Philos Trans Lond 42:514–521
14. Owings MF, Kozak LJ (1998) Ambulatory and inpatient procedures in the United States, 1996. Vital Health Stat 13(139):1–119 [PubMed]
15. Pellettier
JP (1999) The influence of tissue cross-talking on OA progression: role
of nonsteroidal anti-inflammatory drugs. Osteoarthr Cartil 7:374–376 [PubMed]
16. Pezzetti
F, De Mattei M, Caruso A, Cadossi R, Zucchini P, Carinci F, Traina GC,
Sollazzo V (1999) Effects of pulsed electromagnetic fields on human
chondrocytes: an in vitro study. Calcif Tissue Int 65:396–401 [PubMed]
17. Radin EL, Rose RM (1986) Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop 213:34–40 [PubMed]
18. Schuerwegh
AJ, Dombrecht EJ, Stevens WJ, Van Offel JF, Bridts CH, De Clerck LS
(2003) Influence of pro-inflammatory (IL-1 alpha, IL-6, TNF-alpha,
IFN-gamma) and anti-inflammatory (IL-4) cytokines on chondrocyte
function. Osteoarthr Cartil 11(9):681–687 [PubMed]
19. Ulrich-Vinther
M, Maloney MD, Schwarz EM, Rosier R, O’Keefe RJ (2003) Articular
cartilage biology. J Am Acad Orthop Surg 11(6):421–430 (Review) [PubMed]
20. Varani
K, Gessi S, Merighi S, Iannotta V, Cattabriga E, Spisani S, Cadossi R,
Borea PA (2002) Effect of low frequency electromagnetic fields on A2A
adenosine receptors in human neutrophils. Br J Pharmacol 136:57–66 [PMC free article] [PubMed]
21. Varani
K, De Mattei M, Vincenzi F, Gessi S, Merighi S, Pellati A, Ongaro A,
Caruso A, Cadossi R, Borea PA (2008) Characterization of adenosine
receptors in bovine chondrocytes and fibroblast-like synoviocytes
exposed to low frequency low energy pulsed electromagnetic fields.
Osteoarthr Cartil 16(3):292–304 [PubMed]
22. Zorzi
C, Dall’oca C, Cadossi R, Setti S (2007) Effects of pulsed
electromagnetic fields on patients’ recovery after arthroscopic surgery:
prospective, randomized and double-blind study. Knee Surg Sports
Traumatol Arthrosc 15(7):830–834 [PubMed]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008 Nov;22(11):1318-22.
Effects of decimeter wave and sodium hyaluronate product on postoperative adhesions in flexor tendon.
[Article in Chinese]
Tian D, Luo J, Zhang Q, Zhang Y, Liu K, Yu K, Han J, Han J.
Department of Hand Surgery, Third Hospital of Hebei Medical University, Shijiazhuang Hebei 050051, PR China.
Abstract
OBJECTIVE: To compare the effect of decimeter wave with sodium
hyaluronate product (SHP) on preventing and treating peritendinous
adhesion and promoting tendon healing.
METHODS: Totally 96 healthy male white 6-month-old Leghorn chickens
weighing (2.24 +/- 0.07) kg were randomized into group A (decimeter wave
therapy group, n = 32), in which decimeter wave therapy was applied 1
to 21 days after operation at a frequency of 915 MHz, a power of 8 W,
radiation distance of 10 cm, for 10 minutes once per day; group B (SHP
group, n = 32), in which 5 mL and 1.2% SHP was applied; and group C
(control group, n = 32), in which injury received no treatment. The III
and IV toes of left feet of all chickens were made into tendon injury
model. The general condition of animal was observed after operation;
gross and histological observations were made 7, 10, 14, 18, 21 and 28
days after operation, and the biomechanical analysis was done 14 and 28
days after operation.
RESULTS: Operative incision healed well, no infection and death
occurred. Peritendinous adhesions in groups A, B were looser, and tendon
healing was better than that of group C 14 and 28 days after operation.
More fibroblasts with active metabolism and more collagen formation in
groups A, B than that in group C. The Pmax of group A was better than
that of group B 14 and 28 days after operation (P < 0.05); the delta
max of group A was better than that of group B 18 and 21 days after
operation (P < 0.05), and the W0 of group A was better than that of
group B 18, 21 and 28 days after operation (P < 0.05). There was no
significant difference between group A and group B at the other time
points.
CONCLUSION: Topical decimeter wave therapy and application of SHP
after flexor tendon repair can promote intrinsic healing, meanwhile they
can prevent the adhesion of tendon and reduce extrinsic healing.
Decimeter wave therapy can improve the qualities of tendon’s wound
healing.
J Hand Surg Am. 2006 Sep;31(7):1131-5.
Pulsed magnetic field therapy increases tensile strength in a rat Achilles’ tendon repair model.
Department of Plastic and Reconstructive Surgery, Albert Einstein
College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA. bstrauch@montefiore.org
Abstract
PURPOSE: To examine the effect of pulsing electromagnetic fields on
the biomechanic strength of rat Achilles’ tendons at 3 weeks after
transection and repair.
METHODS: This noninvasive modality was tested in a prospective,
randomized, double-blinded, placebo-controlled study to evaluate the
effect of a specific noninvasive radiofrequency pulsed electromagnetic
field signal on tendon tensile strength at 21 days post transection in a
rat model.
RESULTS: In the animals receiving PMF exposure, an increase in
tensile strength of up to 69% was noted at the repair site of the rat
Achilles’ tendon at 3 weeks after transection and repair compared with
nonstimulated control animals.
CONCLUSIONS: The application of electromagnetic fields, configured to
enhance Ca(2+) binding in the growth factor cascades involved in tissue
healing, achieved a marked increase of tensile strength at the repair
site in this animal model. If similar effects occur in humans,
rehabilitation could begin earlier and the risk of developing adhesions
or rupturing the tendon in the early postoperative period could be
reduced.
Radiologe. 2004 Jun;44(6):597-603.
Conservative treatment and rehabilitation of shoulder problems.
The shoulder joint has an important influence on arm- and hand
function. Therefore, activities of daily living, working and leisure
time can be negatively influenced by diseases of the shoulder joint.
Problems of the shoulder joint can be induced by muscular dysbalance and
poor body posture. There is a strong relationship between shoulder
function and body posture. Conservative treatment and rehabilitation of
the shoulder joint aims at improving the local dysfunction of the
shoulder joint as well as at improving function and social
participation. Antiinflammatory and pain medication, exercise,
occupational, electro-, ultrasound and shock wave therapy, massage,
thermotherapy and pulsed electromagnetic fields are used as conservative
treatments. Exercise therapy aims at improving muscular performance,
joint mobility and body posture. Occupational therapy aims at improving
functional movements for daily living and work. Electrotherapy is
primarily used to relieve pain. Shock wave and ultrasound therapy proved
to be an effective treatment for patients with calcific tendinitis. The
subacromial impingement syndrome can be effectively treated by
conservative therapy.
Biomed Sci Instrum. 2002;38:157-62.
Quantitative characterization of rat tendinitis to evaluate the efficacy of therapeutic interventions.
Wetzel BJ, Nindl G, Swez JA, Johnson MT.
Terre Haute Center for Medical Education, Indiana University School
of Medicine, Indiana State University, Terre Haute, IN 47809, USA.
Abstract
Tendinitis is a painful soft tissue pathology that accounts for
almost half of all occupational injuries in the United States. It is
often caused by repeated movements and may result in loss of work and
income. Current treatments for tendinitis are aimed at reducing
inflammation, the major cause of the pain. Although anti-inflammatory
drugs and various alternative therapies are capable of improving
tendinitis, there are no quantitative scientific data available
regarding their impact on inflammation. The objective of this study is
to determine the time course for healing of rat tendinitis without
intervention to be able to assess the efficacy of tendinitis treatments.
We are interested in evaluating the therapeutic use of pulsed
electromagnetic fields (PEMFs), a therapeutic modality that has been
found to be beneficial for healing soft tissue injuries. Tendinitis was
induced in Harlan Sprague Dawley rats by collagenase injections into the
Achilles tendon, and tendons were collected for four weeks post-injury.
To determine the amount of edema, we used caliper measurements of the
rat ankles and quantified the tendon water content. To determine the
extent of inflammation, we estimated the number of inflammatory cells on
histological sections applying stereological methods. The data reveal
that edema is maximal 24 hours after injury accompanied by a massive
infiltration of inflammatory cells. Inflammatory cells are then
gradually replaced by fibroblasts, which are responsible for correcting
damage to the extracellular matrix. This natural time course of tendon
healing will be used to evaluate the use of PEMFs as a possible
therapeutic modality.
Arch Phys Med Rehabil. 1997 Apr;78(4):399-404.
Pulsed magnetic and electromagnetic fields in experimental achilles tendonitis in the rat: a prospective randomized study.
Lee EW, Maffulli N, Li CK, Chan KM.
Department of Orthopaedics and Traumatology, Chinese University of
Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.
OBJECTIVE: To investigate the effects of pulsed magnetic fields (PMF)
and pulsed electromagnetic fields (PEMF) on healing in experimental
Achilles tendon inflammation in the rat.
DESIGN: Prospective randomized trial.
SETTING: University medical school.
METHODS: Exposure of the Achilles tendon and injury by a weight of
98.24 g falling from a height of 35cm in 180 male Sprague-Dawley rats.
INTERVENTION: A daily 15-minute session with PMF of 17Hz or 50Hz, or PEMF of 15Hz or 46Hz, or a sham session.
OUTCOME MEASURES: Random sacrifice 2 hours after the operation, and
at 1, 3, 7, 14, or 28 days. Assessment of water content, weight, and
histological appearance of the tendons.
RESULTS: The time from injury and the various treatment modalities
exerted a significant influence on the water content of the tendon after
the injury (two-way ANOVA, p = .02). At day 3, the water content of the
PEMF 46Hz group was significantly higher than in the other groups,
decreasing sharply by day 7, and being similar to the other groups
thereafter. By the end of the experiment, the PEMF 15Hz group was not
significantly different from the control group. At day 7, the PMF 50Hz
group showed significantly lower water content than the control group (p
= .03), but at 14 days the PMF 50Hz group was not significantly
different from the control group. PMF 50Hz suppressed the extravascular
edema during early inflammation. PMF 17Hz showed a similar initial
trend, producing a consistent lower water content throughout the
experiment, reaching statistical significance by the end of treatment.
By the end of the experiment, the collagen fibers had nearly regained
their normal alignment in all groups, with a more physiological
alignment seen in the PEMF 17Hz group.
CONCLUSIONS: The tendon returned to histological normality in all
groups, but the PMF 17Hz group showed better collagen alignment by the
end of the study. PMF 17Hz resulted in a greater reduction of
inflammation, with a better return of the tendon to histological
normality. Different PMF and PEMF could be applied according to when
treatment is started after the injury. If there is no delay between
injury and beginning of pulsed magnetic treatment, PMF 17 should be
used.
Lancet. 1984 Mar 31;1(8379):695-8.
Pulsed electromagnetic field therapy of persistent rotator cuff tendinitis. A double-blind controlled assessment.
Binder A, Parr G, Hazleman B, Fitton-Jackson S.
The value of pulsed electromagnetic fields (PEMF) for the treatment
of persistent rotator cuff tendinitis was tested in a double-blind
controlled study in 29 patients whose symptoms were refractory to
steroid injection and other conventional conservative measures. The
treated group (15 patients) had a significant benefit compared with the
control group (14 patients) during the first 4 weeks of the study, when
the control group received a placebo. In the second 4 weeks, when all
patients were on active coils, no significant differences were noted
between the groups. This lack of difference persisted over the third
phase, when neither group received any treatment for 8 weeks. At the end
of the study 19 (65%) of the 29 patients were symptomless and 5 others
much improved. PEMF therapy may thus be useful in the treatment of
severe and persistent rotator cuff and possibly other chronic tendon
lesions.